University of South Carolina

Scholar Commons
Theses and Dissertations
2014

The Role of MicroRNA in Staphylococcal Enterotoxin B-Induced
Inflammation and Acute Lung Injury
Roshni Rao
University of South Carolina - Columbia

Follow this and additional works at: https://scholarcommons.sc.edu/etd
Part of the Other Medical Sciences Commons

Recommended Citation
Rao, R.(2014). The Role of MicroRNA in Staphylococcal Enterotoxin B-Induced Inflammation and Acute
Lung Injury. (Doctoral dissertation). Retrieved from https://scholarcommons.sc.edu/etd/3172

This Open Access Dissertation is brought to you by Scholar Commons. It has been accepted for inclusion in
Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please
contact digres@mailbox.sc.edu.

THE ROLE OF MICRORNA IN STAPHYLOCOCCAL ENTEROTOXIN B-INDUCED
INFLAMMATION AND ACUTE LUNG INJURY
By
ROSHNI RAO
Bachelor of Science
Bangalore University, 2006
Master of Science
University of Otago, 2008

Submitted in Partial Fulfillment of the Requirements
For the Degree of Doctor of Philosophy in
Biomedical Science
School of Medicine
University of South Carolina
2014
Accepted by
Mitzi Nagarkatti, Major Professor
Prakash Nagarkatti, Chairman, Examining Committee
Cory Robinson, Committee Member
Angela Murphy, Committee Member
Raja Fayad, Committee Member
Lacy Ford, Vice Provost and Dean of Graduate Studies

DEDICATION

This work is dedicated to my family - my mother, who has been a source of
unconditional love and strength. My father, whose words of wisdom resonate with me in
times of need and my brother, who always makes me laugh.

ii

ACKNOWLEDGEMENTS
“It is good to have an end to journey toward; but it is the journey that matters, in the
end”.
As I ponder over the last five years of graduate school, I clearly see the faces of the
people who have willingly and sometimes unknowingly made what would seem to be a
long, treacherous road ahead, a journey of immense growth, laughter, love and learning
and I would like to take the opportunity to acknowledge them.
First, I thank my mentors Dr Prakash and Dr Mitzi Nagarkatti for providing me with
many opportunities to grow in Science and in leadership. Inspired by their hard work and
dedication they have equipped me with the tools to face the challenges that the next phase
of a scientific career will bring. I am grateful for their support, encouragement and
training.
While laboratory work has sometimes yielded triumphs and most times been frustrating,
it was counting the small blessings that helped persist forward. I owe that encouragement
and consistent support to my fellow graduate students and lab members who I now
consider family. Thank You to my sisters Sadiye Rieder, and Jessica Sido, my friends
Austin Jackson, Brandon Busbee and Sunil Tomar for consistently having my back and a
special Thank You to Michael Rouse for being my pillar of strength, my guide and
confidant in the best and darkest of times. I would like to acknowledge Dr Narendra
Singh for his anecdotes and bits of wisdom that allowed me to stay positive and a Thank
You to Dr Venkatesh Hegde for teaching me the importance of quality of work. A very
iii

special Thanks to Lee Ann Fauling, Tina Akers, Ansley Roberts and Judy Lawrence for
their patience and kindness in taking care of me and the incessant administrative
questions I might have posed. Thank You to Chakira Hogan for a friendship and strength
you provided to face my challenges.
I would like to thank my committee members, Dr Angela Murphy for her guidance,
patience and constant encouragement for the last five years. Dr Cory Robinson and Dr
Raja Fayad for being inspiring scientists and whose guidance and input during my
comprehensive exam I greatly appreciate.
While my time at the University has mainly revolved around the lab, I cannot forget the
friends outside the confines of the School of Medicine who have encouraged, cheered and
egged me on towards completion. My friend Amrita, whose intelligence and mostly her
goodness will always make me want to strive further. Pallavi and Shraddha whose
simplicity and joyfulness keeps me grounded. While you have all journeyed with me
today, know that it is what has shaped me to be better tomorrow.
Finally, my dearest family, Mom, Dad, Karan, Tadeep, Chichi and Suraj for all the
sacrifices that they have made. It is because of all of them and their blessings that I am
excited to begin a brand new chapter of my life.

iv

ABSTRACT
Staphylococcal enterotoxin B (SEB) is a potent activator of the Vβ8+T-cells leading to
the proliferation of nearly 30% of the T-cell pool. As a consequence, excessive amounts
of cytokine mediators are released leading to extensive tissue damage and sometimes
toxic shock and death. Due to the ease with which SEB can be aerosolized
anddisseminated, it is considered a biological weapon. In the current study, we
investigated the pro-inflammatory effects of SEB in two mouse models of acute
inflammatory lung injury. Specifically, while inflammatory cues are known to elicit
changes in key transcriptional factors and gene expression, we explored for the first time,
the role of microRNA following SEB exposure. We found that C57BL/6 mice exposed
to a single dose (50 μg/mouse) of SEB demonstrated symptoms of pulmonary
inflammation characterized by cellular infiltration, histopathological damage and the
release of copious amounts of IFN-γ. Upon conducting microRNA microarray analysis
and applying cutting-edge bioinformatics analysis, we identified the overexpression of
miR-155 and the subsequent repression of its target gene Socs1 following SEB exposure.
Further, through the use of miR-155-/- mice, we demonstrated the critical role for SEBinduced miR-155 in mediating damage. In a more severe model of acute inflammatory
lung injury, C3H/HeJ mice were exposed to two smaller quantities (2 μg and 5μg/ mouse)
of SEB given two hours apart. As a result, mice succumb to vascular leak, excessive
cellular infiltration and exaggerated cytokine and chemokine release. Pulmonary damage
is associated with the dysregulation of several miRNA. Those miRNA that were
v

overexpressed were found to target key regulators of inflammation and those that were
underexpressed allowed for the expression of pro-inflammatory genes demonstrating that
several SEB-inducing miRNA act in concert to orchestrate inflammation. Therapeutic
strategies to combat inhalation exposure to SEB are either lacking in their efficacy or
with regards to acute inflammatory lung injury, limited to supportive care. As a result, we
investigated the role of the marijuana cannabinoid- Delta-9-Tetrahydrocannabinol(THC),
a known anti-inflammatory agent in the treatment of SEB-triggered inflammation.
Interestingly, C3H/HeJ that succumbed to SEB toxicity, were completely protected by
THC treatment. Upon investigation of the anti-inflammatory nature of THC, we
demonstrated for the first time the ability of THC to modulate a prominent inflammatory
miRNA cluster (miR-17-92) involved in activation of the PI3K/AKT signaling pathway
THC, by acting as an inhibitor of this pathway, via the downregulation of the cluster,
induces T-regulatory cells, reduces cellular proliferation and decreases IFN-γ production.
Taken together, our studies highlight the importance of miRNA in SEB-induced
inflammatory damage. Moreover, we provide further insight into the anti-inflammatory
properties of THC and emphasize its potential as a powerful therapeutic agent.
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CHAPTER I: INTRODUCTION

1.1 STAPHYLOCOCCAL ENTEROTOXIN B (SEB)
The gram positive bacterium Staphylococcus aureus is an opportunistic pathogen that
persistently colonizes up to 20% of healthy humans thereby increasing their susceptibility
to infections (Kuehnert et al., 2006; Wertheim et al., 2005). Some of the most common
infections caused by the pathogen are, bacteremia, endocarditis, septic shock, food-borne
gastroenteritis and toxic shock syndrome making Staphylococcus aureus a leading cause
of community and hospital acquired morbidity (Frank et al., 2010; Huang et al., 1998).
The bacterium possesses an arsenal of virulence factors that contribute to its
pathogenesis. Some of these factors include the expression of surface proteins to aid in
adhesion, the formation of biofilms to enable persistence , the secretion of enzymes such
as proteases and lipases to ensure immune evasion and importantly, the production of
inflammation inducing- enterotoxins (Archer, 1998; Gordon et al., 2008).
Staphylococcal enterotoxins (SEs) are a group of ~23-30 kDA secreted, acid and
heat stable proteins that share amino-acid sequence homology and are functionally
similar (Balaban et al., 2000). Structurally, although these proteins all comprise of tightly
packed β-sheets and α-helical domains separated by a shallow groove, they differ in their
interaction with the major histocompatibility class II (MHC II) and in their T-cell
receptor specificity (Argudin et al., 2010). Amongst the large group of SEs (SE A-V and
toxic shock staphylococcal toxin-1, the TSST-1), SEA and SEB are the best studied.
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While, SEA is the most common toxin associated with staphylococcal food poisoning
(Pinchuk et al., 2010), the focus of our study is SEB. SEB is the only SE studied with
regards to its role as a potential biological weapon. Since it is easy to produce in the
laboratory, is a stable and robust protein and can be easily aerosolized, the Center for
Disease Control and Prevention (CDC) has classified SEB as a ‘select’ agent (Pinchuk et
al., 2010). In fact, the study of SEB was carried out in the 1960’s when the USA had an
active offensive biological warfare program. Since then, a number of facets of SEB
exposure have been elucidated.
SEB exposure elicits a wide range of symptoms depending on the site of entry.
Ocular exposure to SEB leads to conjunctivitis, while the ingestion of SEB results in
nausea, vomiting and diarrhea within 6 hours of exposure. The inhalation of the toxin can
lead to fever, respiratory damage, acute respiratory distress syndrome (ARDS) and death.
Furthermore, exposure to the toxin under battlefield-induced stress exacerbates the
severity of symptoms which include vasodilation and drop in blood pressure.
The potency of SEB stems from the fact that it is a superantigen, a term used to
describe antigens that hyper-activate the immune system. Unlike conventional antigens
that undergo antigen processing by an Antigen Presenting Cell (APC) and are displayed
to a T-cell via the MHC II, leading to the activation of a fraction (~0.001%) of T-cells, a
superantigen, strongly stimulates T-cells comprising the Vβ8 domain of the T-cell
receptor independent of antigen recognition and processing. As a result, up to 30% of the
T-cells are activated and clonally expanded. This initial binding is followed by
engagement of co-stimulatory molecules such as CD69, CD28, CD80 that help sustain
activation and trigger downstream signaling cascades such as the MAPK, PI3K/AKT,
2

NFκB pathways. It is well established that several cytokines such as IL-1, TNF-α, IL-2,
IFN-γ, IL-6, MCP-1 are induced upon activation of these key inflammatory signaling
pathways. The release of these cytokines after SEB exposure results in further
proliferation of T-cells and the recruitment of other immune cell subsets. Thus, SEB
exposure involves the activation of the immune system and the establishment of a strong
inflammatory environment that can now mediate extensive tissue damage.
Treatment against the harmful effects of SEB exposure has previously been
explored and has shown some therapeutic promise. For example, the use of a
combination of monoclonal antibodies confers protection from SEB-induced toxic shock
in HLA DR3 transgenic mice (Varshney et al.). The use of synthetic peptides elicits antiSEB antibodies (Visvanathan et al., 2001) and mimetic peptides of CD28 decrease
production of IL-2, IFN-γ thereby protecting mice from SEB-induced shock (Chen et
al.).In addition, the use of immunosuppressive glucocorticoids such as Dexamethasone
and Rapamycin have demonstrated protective effects in mice exposed to SEB by
blocking SEB-induced cytokines and chemokines and suppressing NFκB activation. On
the other hand, several other therapeutic strategies to combat SEB exposure have been
limited in their efficacy. For example, SEB-peptide antagonists are unable to prevent Tcell activation and cytokine production in vitro and in vivo in HLA II transgenic mice
(Tilahun et al., 2011). The use of TCR Vβ8 mimics that interfere with the binding of SEB
have short half-lives in rabbits and would prove ineffective in the clinic (Strandberg et
al.).
In conclusion, SEB, by virtue of being a superantigen, elicits a strong immune
response characterized by cellular proliferation, excessive release of cytokines and
3

chemokines and the simultaneous activation of several key inflammatory pathways. As a
result, exposure to the toxin has a number of far reaching effects in humans ranging from
food poisoning to death. While a number of treatment modalities have been studied to
combat the toxicity induced by SEB, therapeutic interventions that are efficacious and
manage inflammation in the clinical setting is still lacking.
1.2 microRNA
Cells contain a number of non-coding RNA (ncRNA) that are structural, catalytic or
regulatory in function but do not encode protein (Eddy, 2001). One such class of small
regulatory non-coding RNAs that are newly discovered and have generated significant
interest in the scientific community is microRNA (miRNA).
The first miRNA- lin-4 and let-7 were identified in C. elegans and found to be
critical in the developmental stages of the nematode. It was observed that lin-4 was
partially complimentary to the 3’ Untranslated region (UTR) of lin-14 and lin28, genes
that encode protein necessary for the progression of larval stages. Similarly, let 7 bound
to the 3’UTR of lin-41 and hbl-1, hindering development of the worm (Lin et al., 2003;
Sasaki et al., 2010; Vella et al., 2004). This discovery, hinted towards a novel form of
gene regulation that could influence development and prompted the exploration of these
miRNA in other species. Since then, hundreds of miRNA have been identified in plants,
animals, viruses and unicellular algae and at least a thousand miRNA have been found in
humans likely regulating 30-90% of genes (Dai et al., 2011; Molnar et al., 2007). These
miRNA serve as key regulators of genes in myriad biological processes such as cellular
proliferation, differentiation, signal transduction, development of organs, apoptosis and
immune response (Sonkoly et al., 2008).
4

The biogenesis of miRNA begins with the transcription of primary miRNA
transcripts (pri-miRNA) by RNA polymerase II that are up to thousands of nucleotides
long and contain hairpin structures. Classically, the pri-miRNA is processed and cleaved
in the nucleus by a complex known as the Microprocessor comprising of RNase III
enzyme Drosha and the double-stranded RNA binding domain protein DGCR8 yielding a
~70 nt precursor miRNA (pre-miRNA). Exportin 5 subsequently transports the premiRNA into the cytoplasm where it is cleaved by RNase III enzyme Dicer to yield a ~22
nucleotide mature miRNA: miRNA* duplex product. This duplex is loaded into the
Argonaute (Ago) protein to form a RNA-inducing silencing complex (RISC). Following
the degradation of the miRNA* strand within the RISC, the miRNA strand that remains,
guides the RISC to mRNA targets and allows for the interaction of the miRNA with the
3’UTR of target mRNA. 2-8 nucleotide regions within the 3’UTR, known as seed
sequences are important for the miRNA recognition of the target gene. Consequently,
mRNA is cleaved and degraded if the miRNA displays perfect or near-perfect
complementarity to the 3’UTR, otherwise, as is the case with most miRNA, the miRNA
and its respective target base-pair imperfectly resulting in the repression of translation
(Bushati et al., 2007; Plaza et al., 2004).
As mentioned above, miRNA have been found to regulate almost every cellular
process in the body. This includes actively participating and orchestrating the
development and function of the innate and adaptive arm of the immune system. A few
studies have identified miRNA in the regulation of hematopoietic stem cells (HSC),
where CD34+ human stem and progenitor cells express numerous miRNA (Georgantas et
al., 2007; Mandal et al., 2005). The Homeobox (HOX) family of genes which are
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important in the regulation of HSC stem cells, are targeted by individual miRNA such as
miR-196b, miR-126 (Shen et al., 2008; Yekta et al., 2004). Furthermore, the role of
miRNA has also been established in the function and development of dendritic cells
(DC), macrophages, Natural killer (NK) cells, granulocytes and monocytes. For example,
miR-223 targets transcription factor E2F1, which results in increased granulocyte
differentiation (Pulikkan et al.). miR-424 enhances monocyte differentiation by binding
NFI-A which in turn causes the activation of macrophage colony-stimulating factor
receptor (M-CSFR) (Rosa et al., 2007). Similar to their roles in the innate system,
miRNA control the development, differentiation and function of cells of the adaptive
arm. For example, the miR-17-92 cluster increases T-cell survival during the double
negative 2 (DN2) stage of thymopoiesis. The absence of this cluster, also leads to the
lymphoproliferation of B and T-cells (Xiao et al., 2008). miR-181a functions to enhance
TCR signaling strength (Greenhough et al., 2007), while miR-155 promotes Th1
differentiation (Plaza et al., 2007). Furthermore, the conditional deletion of Dicer or
Drosha in T-regulatory (T-regs) cells causes lethal autoimmune inflammatory disease
(Zhou et al., 2008). Thus, given that miRNA are critical regulators of gene expression, it
is not surprising that they also control aspects of the immune system. By serving as fine
tuners of important stages of development and differentiation, they maintain and enable
proper immune response and homeostasis. However, what is interesting to this study is
the possibility of a strong dysregulation of miRNA. For instance, what is the role of
miRNA during inflammatory response and disease? By regulating important
inflammatory genes and transcription factors, can miRNA be implicated in
inflammation? Can we target key miRNA involved in inflammatory disease and thus
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prevent inflammatory damage? While several studies have already sought to answer
some of these questions a brief overview of miRNA in inflammation is presented below.
Inflammation is important for host defense against pathogens. However, the
hyperactivation of the inflammatory response triggered by exposure to bacterial LPS,
peptidoglycan, enterotoxins such as SEB can cause host tissue damage and disease. It is
important that molecules that govern the initiation, progression and resolution of
inflammation be properly regulated. While an inflammatory insult elicits intricate
changes in the transcriptional landscape, we have now learned that the dysregulation of
miRNA accompany these molecular changes. For example, murine macrophages
activated with Poly (I:C) and interferon β results in the activation of the MAP kinase
JNK, which in turn leads to the induction of miR-155(O'Connell et al., 2007). Similarly,
the overexpression of miR-21 in myeloma cells is dependent on the expression of STAT3
(Loffler et al., 2007). miR-146a is induced upon lipopolysaccharide (LPS) stimulation in
human monocytes to function as a negative regulator of Toll-like receptor (TLR)
signaling by targeting TRAF6 and IRAK4 (Baltimore et al., 2008).
Evidently, inflammatory cues alter the expression of several miRNA. Moreover,
aberrant expressions of several miRNA have been implicated in inflammatory disease
and autoimmunity. miR-326 is overexpressed in Multiple Sclerosis (MS) and plays a role
in Th17 cell differentiation (Miethke et al., 1993). Murine models of arthritis have
demonstrated the role for miR-182 in regulating B and T-cell function (Stittrich et al.).
Similarly, the introduction of synthetic let-7 mimic to mice in asthma represses IL-13 and
ameliorates airway inflammation(Polikepahad et al.).
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In summary, miRNA have arisen as important regulators of gene expression
serving critical roles in mammalian inflammatory response. Given that several miRNA
target a number of potential genes and owing to the infancy of the miRNA field, a
number of features of miRNA-mRNA interactions remain to be uncovered. Nevertheless,
we have begun to carefully study the role of individual miRNA in disease process to
identify novel biomarkers, establish unique therapeutic agents that can directly modulate
them with the ultimate goal of curing and preventing inflammation and disease.
1.3 DELTA-9 TETRAHYDROCANNABINOL (THC)
The flowering tops and leaves of the cannabis sativa (marijuana) plant contain
biologically active constituents known as cannabinoids. Amongst the approximately 60
cannabinoids produced, Delta-9-Tetrahydrocannabinol (THC) is the major psychoactive
component (Klein et al., 2001). Although anecdotal evidence regarding its therapeutic
properties has existed for thousands of years, it was the isolation and elucidation of its
structure in 1964 that prompted its study. Since then, a number of synthetic analogues
have been developed that mimic its analgesic, anti-emetic and immunomodulatory
properties in vivo.
Cannabinoids mediate their action through the ligation of two main
cannabinoid receptors, the CB1 and CB2. These receptors are G-protein coupled single
polypeptides with an extracellular N-terminus and intracellular C-terminus with seven
transmembrane helices. While the CB1 receptor is predominantly located on the
hippocampus and basal ganglia in the brain, it is also expressed on peripheral tissues such
as the liver, pancreas and immune cells. The CB2 receptor is mainly expressed in the
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periphery and particularly in immune cells such as B-cells, NK cells, monocytes,
Peripheral mononuclear cells (PMN) and T-cells (Klein et al., 2003).
The presence of CB receptors on immune cells suggests that cannabinoids are
immunomodulatory. THC in particular has demonstrated a number of anti-inflammatory
properties such as the modulation of cytokines, the modulation of T-cells and the
induction of apoptosis (Nagarkatti et al., 2009). For example, splenocytes activated with
pokeweed mitogen (PWM) and treated with THC lead to a decrease in Th1 cytokine
IFNγ and simultaneous increase in Th2 cytokines IL-4 and IL-10 (Newton et al., 1998).
Similarly, THC treatment of mice given Legionella pnuemophila succumbed to infection
due to the decrease in IFNγ and IL-12 and the increase in IL-4, suggesting that the THC
mediated Th1 to Th2 cytokine shift contributed to enhanced infection (Klein et al., 2000).
THC has also been demonstrated to induce apoptosis in T-cells, B-cells and macrophages
(Nagarkatti et al.). Furthermore, THC mediated apoptosis was found to be mediated
through BCL2 and the activation of caspases (Nagarkatti et al., 2009). Our laboratory has
demonstrated that THC also induced immunosuppressive immune cells. For example, in
a mouse model of Con-A induced hepatitis, THC treatment ameliorated liver injury by
the induction of Foxp3+ T-regulatory cells(Hegde et al., 2008). We have also observed
that THC induces functional myeloid derived suppressor cells (MDSC) through the
activation of the CB1 and CB2 receptors further demonstrating the potent antiinflammatory properties of THC (Hegde et al.).
Recently, we have reported novel mechanisms of action for THC. It appears
that THC can activate the expression of Th2 cytokine genes, while suppressing the
signals to Th1 cytokines via histone modifications (Yang et al.). Moreover, we have also
9

found that THC-induced MDSCs displayed a distinct miRNA profile compared to
MDSCs derived from naïve bone marrow, suggesting that THC induced miRNA may
play a functional role in the development of these MDSCs (Hegde et al.).
In conclusion, although a number of studies have explored the role of THC as an antiinflammatory agent and have established its efficacy in modulating immune response, we
are only now discovering unique properties that underlie its mechanism, the examination
of which will enable us to further exploit its therapeutic properties.
1.4 PROBLEM AND HYPOTHESIS
The superantigenic property of SEB makes it an ideal candidate to be used as a biological
weapon. Studies have established that exposure to the toxin results in an exaggerated
immune response due to the secretion of a number of inflammatory mediators. With the
discovery that inflammatory cues can trigger the expression of a unique class of gene
regulators, the miRNA, it was unclear if SEB exposure would affect the miRNA profile
in mice and if the miRNA played a role in SEB-mediated damage to the lung. Therefore,
we hypothesized that exposure to the toxin results in the dysregulation of miRNA.
Furthermore, we also wanted to establish the role of the marijuana derived cannabinoid,
THC, known for its anti-inflammatory properties in ameliorating SEB-induced acute
inflammatory lung injury. Accordingly, we hypothesized that THC treatment would
prevent SEB-mediated mortality of mice and does so by the modulation of inflammation
specific miRNA.
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CHAPTER II: Staphylococcal enterotoxin B (SEB) - induced microRNA-155 targets
suppressor of cytokine signaling-1 (SOCS1) to promote acute inflammatory lung injury.
2.1 INTRODUCTION
Staphylococcal Enterotoxin B (SEB), a superantigen produced by Staphylococcus aureus
has deleterious effects in humans such as food poisoning (Pinchuk et al., 2010) and toxic
shock (Savransky et al., 2003). Because it can be easily aerosolized, SEB is classified as
a Category B agent by the Centers for Disease Control and Prevention (Ulrich, 2001).
Upon inhalation exposure, SEB can trigger acute inflammatory lung injury characterized
by immune cell infiltration, excessive cytokine production, tissue damage and pulmonary
edema (Neumann et al., 1997; Saeed et al.).
Due to the distinct manner in which SEB binds to the non-polymorphic regions of
MHC II on antigen presenting cells and the specific Vβ regions of the T-cell receptor
(TCR) such as murine Vβ8 (Bavari et al., 1995), SEB exposure leads to the activation
and proliferation of a large population (5-30%) of T-lymphocytes (Kozono et al., 1995).
Activation of such a substantial number of T-lymphocytes results in the robust production
of inflammatory cytokines such as IL-2, TNF-α and IFN-γ (Bette et al., 1993; Miethke et
al., 1993). In most cases, IFN-γ is the main culprit in mediating the damaging and often
lethal effects seen upon SEB exposure. For example, transgenic mice deficient in IFN-γ,
were protected from SEB-mediated Toxic Shock Syndrome (TSS) and
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subsequent mortality(Tilahun et al., 2011). Additionally, the neutralization of IFN-γ, after
SEB exposure was shown to prevent lethal systemic inflammation (Florquin et al., 1995)
further suggesting the importance of SEB-mediated IFN-γ production. While the
interaction between SEB and TCR, along with the subsequent T-cell proliferation and
cytokine secretion have been extensively studied (Fleischer et al., 1991; Herman et al.,
1991; Saeed et al., 2012), the role of miRNA in mediating SEB-induced inflammation
has not yet been elucidated.
MicroRNA (miR) are ~21-23 nt long, single stranded non-coding RNA molecules
that can translationally repress or target mRNA for degradation, thereby acting as
primary modulators of gene expression (Cai et al., 2009). Several studies have
demonstrated a role for miR in modulating immune responses under various
inflammatory conditions (O'Connell et al., 2012). For example, while miR-125b is highly
expressed in naïve CD4+ T-cells, it becomes significantly downregulated upon T-cell
activation (Rossi et al., 2011). Similarly, studies have demonstrated that overexpression
of miR-17-92 cluster in T-cells leads to lymphoproliferative disorder due to the
repression of the pro-apoptotic molecule, BIM (Xiao et al., 2008). Furthermore, mice
deficient in miR-155 are resistant to developing experimental autoimmune
encephalomyeltis, a mouse model of multiple sclerosis (O'Connell et al., 2010), while the
overexpression of miR-155 exacerbates the symptoms associated with the disease.
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Taken together, these studies strongly suggest that miRs play a major role in modulating
immune cell activation, particularly T-cells, as well as promoting pro-inflammatory
responses.
In the current study of SEB-induced acute inflammatory lung injury, we applied
microarray analysis and quantitative real time PCR (q-RT PCR) to establish important
miRs that are dysregulated in response to SEB. Further, our data identified miR-155 as a
major contributor to SEB-mediated lung inflammation. While it is known that SEB
exposure leads to inflammation and the production of copious amounts of IFN-γ, we
provide mechanistic insight through gain and loss of function experiments, into the role
of miR-155 in this process. Our results may present an opportunity to further
therapeutically target miR-155 in the treatment of SEB-mediated acute inflammatory
lung injury.
2.2 MATERIALS AND METHODS
Mice
Female C57BL/6 mice (6-8 weeks) were purchased from the National Cancer Institute
(NCI). miR-155-/- (B6.Cg-Mir155 tm1.1 Rsky/J) were purchased from The Jackson
laboratory. All mice were housed under pathogen free conditions at the Animal Resource
Facility (ARF), University of South Carolina (USC) School of Medicine. The use of
vertebrate animals in the experiments performed was pre-approved by the Institutional
Animal
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Care and Use Committee (IACUC) at USC. This study was carried out in strict
accordance with the recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Research Council (2011)
Induction of SEB-induced acute lung injury (ALI)
SEB was obtained from Toxin Technologies (Sarasota, Florida). SEB dissolved in sterile
PBS (2 mg/mL) was administered by the intranasal (i.n) route in a volume of 25 μL for a
dose of 50 μg per mouse, as described (Rieder et al., ; Rieder et al., ; Saeed et al.) . Mice
were euthanized 48 hours after SEB exposure.
Lung histopathological analysis
At the time of euthanasia, lungs were obtained and fixed in 10% formalin. The tissue
was then paraffin embedded and serial sections (5 μm) were made. The sections were
subsequently deparaffinized by dissolving with xylene, followed by rehydration in
several changes of alcohol (100%, 95%, and 90%). The slides were then stained with
hematoxylin and eosin (H&E) and evaluated with a Nikon E600 light microscopy system.
Antibodies
Fluorescein isothiocyanate-conjugated anti-CD8 (clone: 53.6.7) and phycoerythrinconjugated anti-CD4 (clone: GK1.5) Abs were purchased from Biolegend (San Diego,
CA).
Preparation of lung-infiltrating cells and flow cytometry
Mice were exposed to SEB as described above. Forty eight hours after SEB exposure,
lungs were harvested and homogenized using Stomacher® 80 Biomaster blender from
Seward (Davie, FL) in 10 ml of sterile PBS. After washing with sterile PBS, the cells
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were carefully layered on Ficoll - Histopaque ®-1077 from Sigma-Aldrich (St Louis,
MO) and separated by density gradient centrifugation at 500 x g for 30 minutes at 24°C
with brake off. The mononuclear cell layer isolated was then enumerated using the
Trypan blue exclusion method. To determine the subsets of immune cells infiltrating the
lung, cells were stained with fluorescent conjugated antibodies (anti-CD4, anti-CD8) and
analyzed using the Beckman Coulter 500 Flow cytometer (Indianapolis, IN).
Recovery of broncheoalveloar lavage fluid (BALF) and cytokine detection
Forty-eight hours after SEB exposure, mice were euthanized and tracheae from vehicle or
SEB exposed mice were tied with a suture and the lung was excised as an intact unit.
With 1 ml sterile ice-cold PBS, the trachea was lavaged to collect the BALF fluid.
Cytokine analysis for interferon-γ (IFN-γ) was carried out using BALF. All cytokines
were measured using Biolegend (San Diego, CA) ELISA MAX™ Standard kits.
Total RNA isolation
Total RNA (including small RNAs) was isolated from lung-infiltrating mononuclear cells
or in vitro from lymph nodes or splenocytes using miRNeasy kit from Qiagen (Valencia,
CA) following manufacturer’s instructions. The purity and concentration of the RNA was
confirmed spectrophotometrically, while the integrity of miRNA was further assessed
using Agilent 2100 BioAnalyzer (Agilent Tech, Palo Alto, CA).
miRNA expression profiling and analysis
To profile miRNA expression in the lung, the Affymetrix GeneChip ® miRNA 1.0 array
platform was used. The array which comprises of 609 mouse miRNA probes makes use
of FlashTag™ Biotin HSR hybridization technique and was carried out according to
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manufacturer’s instructions (Affymetrix, Santa Clara, CA). Fluorescent intensities
obtained from hybridization were log-transformed and visualized in the form of a
heatmap. Hierarchical clustering was carried out using Ward’s method and Similarity
measurement was calculated using half square Euclidean distance. miRNA expression
fold change obtained from the microarray were then further analyzed using the
commercially available analysis tool Ingenuity Systems®-Ingenuity Pathway analysis –
(IPA), (Mountain View, CA, USA.) In brief, the dataset of 609 miRNA were uploaded
into IPA and only miRNA that were 3 fold or higher were considered for analysis. Core
analysis was carried out and a ‘Top Network’ of miRNA and its associated molecules
was generated. All microRNA microarray data were deposited in ArrayExpress database
(www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-2379.
Analysis of miRNA target genes
IPA was also used to determine and collate the highly predicted, moderately predicted
and experimentally observed mRNA target genes of those miRNA that were highly (≥3
fold) upregulated using IPA’s miRNA target filter tool. These targets were further sorted
based on their role in cytokine signaling, cellular growth and proliferation and cellular
immune response. Additionally, to assign Immunological functions to our list of miRNA
targets, Gene Ontology (GO) mapping of miRNA target genes was carried out using
Cytoscape 3.0.1 equipped with ClueGO and CluePedia applications.
Quantitative real-time PCR (qRT-PCR)
Total RNA (miRNA and mRNA) were converted to cDNA using the miScript cDNA
synthesis kit (Qiagen) according to manufacturer’s instructions. For miRNA validation,
the miScript SYBR Green PCR kit (Qiagen) was used and fold change of miRNA was
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determined using 2-ΔΔCt method. Snord 96a was used as small RNA endogenous control.
For mRNA validation, SSO advanced™ SYBR Green PCR kit from Biorad (Hercules,
CA) was used according to manufacturer’s instructions and β-actin was used as the
endogenous control. The following primers were used: β-actin (F) 5’GGCTGTATTCCCCTCCAT G-3’ and (R) 5’-CCAGTT GGTAACAATGCCATGT-3’;
SOCS-1 (F) 5’-GGTTGTAGCAGCTTGTGTC-3’ and (R) 5’AATGAAGCCAGAGACCCTC-3’; IFN-γ (F) 5’-GCGTCATTGAATCACACCTG-3’
and (R) 5’-GAGCTCATTGAATGCTTGGC-3’
Transfection with miR-155 mimic and inhibitors
Lymph nodes (axillary and inguinal) from naïve C57Bl/6 mice were harvested and
cultured in 10 ml of complete media at 37° C and 5% CO2. Complete media comprised
of RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10%
FBS, 10mM L-glutamine, 10mM Hepes, 50 μM β-Mercaptoethanol , and 100 μg/mL
penicillin. Cells were seeded at 2x105 cells in 24 well plates and transfected with either
40 nM synthetic mmu-miR-155 -3p miScript miRNA mimic
(CUCCUACCUGUUAGCAUUAAC) or AllStar negative control siRNA. For inhibition
of miR-155, cells were activated with SEB (1 μg/ml) and treated with 100 nM Antimmu-miR-155-3p miScript miRNA inhibitor (CUCCUACCUGUUAGCAUUAAC) or
miScript Inhibitor negative control for 24 hours using HiperFect transfection
reagent(Qiagen) according to manufacturer’s instructions.
Luciferase assay
The following plasmids were purchased from GeneCopoeia (Rockville, MD) – 3’UTRSocs1 (MmiT028883) and control plasmid (CmiT000001-MT01). Chinese Hamster
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Ovary (CHO) cells were co-transfected with 100 ng of plasmid and 100nM of miRIDIAN
microRNA mmu-miR-155-5p mimic or miRIDIAN microRNA mimic negative control
using DharmaFECT DUO transfection reagent following manufacturer’s instructions
(Thermo Scientific, Pittsburgh, PA). 24 hr following transfection, Luciferase activity was
measured using LucPair ™ miR-Duo Luciferase Assay kit from GeneCopoeia.
Statistics
All statistical analyses were carried out using GraphPad Prism Software (San Diego,
CA). In all experiments, the number of mice used was 4-5 per group, unless otherwise
specified. Results are expressed as means ± SEM. Student’s t-test was used to compare
WT and miR-155-/- data, whereas multiple comparisons were made using one-way
analysis of variance (ANOVA), followed by post hoc analysis using Tukey’s method. A
p-value of <0.05 was considered statistically significant. Individual experiments were
performed in triplicate and each experiment was performed independently at least three
times to test reproducibility of results.
2.3 RESULTS
SEB exposure triggers inflammation in the lung.
Previously, a single dose of SEB (50 μg) by intranasal delivery was found to induce
cellular infiltration, increase cytokine production, cause histopathological lesions and
edema in C57BL/6 mice (Rieder et al., ; Rieder et al., ; Saeed et al.) mimicking the
symptoms of acute inflammatory lung injury in humans (Wheeler et al., 2007). In this
study, we first sought to investigate the inflammatory effect of SEB-exposure in the
lungs. Forty -eight hours after SEB exposure, H&E stained sections of the lungs from
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SEB-exposed mice showed massive infiltration of cells and signs of edema as evidenced
by fluid filled bronchioles (Figure 2.1A). Because SEB is a potent activator of T-cells, we
examined the effect of SEB on T-cell subsets within the lung. Immediately after
euthanasia, the lungs were harvested and mononuclear cells were isolated from the lungs
by density gradient centrifugation to determine the phenotypic characteristics of the cells.
SEB exposure not only led to an overall increase in mononuclear cells but specifically, an
increase in CD4+ and CD8+ T cells (Figure 2.1B) was seen. Because SEB exposure
triggers an increase in IFN-γ, a major pro-inflammatory cytokine previously reported to
orchestrate the inflammatory cascade and cause tissue damage(Miyata et al., 2008; Plaza
et al., 2007; Tilahun et al., 2011), we analyzed the concentration of IFN-γ in the
broncheoalveolar lavage fluid (BALF) and found a high concentration (upto 3000 pg/ml)
of IFN-γ in the lungs of SEB exposed mice (Figure 2.1C). These data suggested that SEB
administration via the intranasal route triggers acute inflammation in the lungs.
SEB exposure modulates miRNA expression in the lungs.
The dysregulation of specific miRs in response to SEB exposure has not been elucidated.
Because miRs play a critical role in mediating inflammation, we examined the miR
profile after SEB exposure. Total miR was isolated from lung-infiltrating mononuclear
cells and the relative abundance of miR in SEB exposed and vehicle treated mice was
determined using microarray miRNA analysis. A heatmap was generated based on
hierarchical clustering of miRNA highlighting a stark difference between vehicle- and
SEB-exposed mice (Figure 2.2A). Further examination of miR expression revealed that
of the 609 miR assessed, most remained unchanged, but a few showed significant up- or
downregulation as seen in the fold change distribution plot (Figure 2.2B). Ingenuity
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Pathway Analysis (IPA) generated a ‘Top Network’ of miR that comprised of five
upregulated miRs, including miR-155, miR-31, miR-182, miR-20b, and miR-222 and
their associated molecules (Figure 2.2C). This network was characterized by IPA as
responses involving inflammation, cellular development, cellular growth and
proliferation. To assign significant Immunological functions to the genes in the
aforementioned ‘Top Network’, Cytoscape (ClueGO+CluePedia application) was
employed. Gene Ontology (GO) mapping revealed that the genes associated with the miR
in the ‘Top Network’ were functionally relevant to T-cell activation (GO: 0042110) and
proliferation (GO: 0042098), Interferon-γ signaling (GO: 0060333) and Toll-like receptor
signaling (GO: 0002224) (Figure 2.2D). Next, we validated the expression levels of
these miRs in lung infiltrating mononuclear cells by q-RT PCR , which corroborated the
expression patterns seen using the microarray (Figure 2.2E). Amongst the miRs we
validated, miR-155 was the most highly expressed (~ 8 fold) in the lungs upon SEB
exposure. Based on this, the role of miR-155 in the development of SEB-induced ALI
was further investigated.
miR-155 is important for SEB-mediated inflammation
Because miR-155 was highly upregulated in response to SEB, we hypothesized
that it might play a crucial role in facilitating the inflammation observed during the
disease. To that end, WT and miR-155 -/- mice were exposed to SEB to determine the
effects on disease parameters. H&E stained sections of the lung revealed that WT mice
exposed to SEB exhibited numerous layers of infiltration interspersed with edema.
Interestingly, miR-155 -/- mice exposed to SEB presented with almost normal lung
architecture (Figure 2.3A). Additionally, the miR-155 deficient mice expressed
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significantly decreased total numbers of mononuclear cells within the lung upon SEB
exposure when compared to their WT counterparts. Upon closer examination of the
mononuclear cell phenotype within the lungs, absolute numbers of CD4+ and CD8+ in
the miR-155 -/- mice were decreased compared to WT mice (Figure 2.3B). Additionally,
cytokine analysis of the broncheoalveolar lavage fluid (BALF) in the lungs of WT mice
demonstrated high concentrations of pro-inflammatory cytokine IFN-γ. In contrast, IFN-γ
levels were significantly diminished in miR-155-/- mice (Figure2.3C). Taken together,
these results provided clear evidence that miR-155-/- mice were protected from SEB
mediated ALI, suggesting that miR-155 plays a critical role in SEB-induced
inflammation.
miR-155 expression is critically linked to IFN-γ production
Because SEB exposure leads to the release of copious amounts of IFN-γ and also results
in increased miR-155 expression, we considered if there was a positive correlation
between IFN-γ secretion and the expression of miR-155. To explore this possibility, we
first assessed the expression of IFN-γ after transfection of LN T-cells with a synthetic
miR-155 mimic. Interestingly, we found a substantial increase in IFN-γ levels not only in
WT mice (Figure2. 4A) but also in miR-155 deficient mice that were transfected with the
mimic (Figure 2.4B). Additionally, inhibition of miR-155 with a synthetic inhibitor
conversely resulted in the diminished expression of IFN-γ (Figure 2.4C), suggesting a
crucial link between miR-155 expression and that of IFN-γ after SEB exposure.
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miR-155 targets Socs1, a negative regulator of IFN-γ
miRs regulate the expression of genes by binding the 3’UTR of their respective target
mRNA. To examine the link between miR-155 and its potential target genes, we
undertook a bioinformatics-based approach. First, IPA miRNA target filter tools were
used, selecting only those miR-155 target genes that were relevant to cytokine signaling,
cellular immune response, and cellular growth and proliferation. Thirty six targets
common to the filtering criteria applied were selected (Figure 2.5A). Next, an IPA
generated network was used to sort the targets based on those that were highly predicted
and experimentally observed (Figure 2.5B). Conclusively, a gene known as suppressor
of cytokine signaling-1 (Socs1) was found to be a prominent miR-155 target due to miR155’s ability to bind to the 3’ UTR of the Socs1mRNA (Figure2. 5C). Because Socs1 is
induced by IFN-γ and acts a negative regulator of IFN-γ, the relationship between miR155 and Socs1 in the context of IFN-γ production was examined. miR-155-/- mice that
were exposed to SEB had significantly increased expression of Socs1 mRNA in lung
infiltrating mononuclear cells when compared to WT (Figure 2.5D). Accordingly, we
hypothesized that miR-155 may target Socs1 to promote IFN-γ-mediated inflammation
during SEB-induced inflammatory ALI. To confirm Socs1 as a miR-155 target, we first
measured relative luciferase activity after co-transfection of miR-155 mimic and plasmid
containing the 3’ UTR of Socs1. Compared to mimic control, miR-155 mimic led to a
significant decrease in luciferase activity (Figure 2.6A) validating Socs1 as a target for
miR-155. Next, the impact of miR-155 mimic on Socs1 levels was explored. We found
that both, in WT (Figure 2.6B) and miR-155 deficient cells (Figure 2.6C) that were
transfected with miR-155 mimic, Socs1 levels remained suppressed .On the other hand,

22

whereas SEB activation continued to lead to a repression in Socs1, miR-155 inhibition of
SEB-activated cells, resulted in its derepression (Figure 2.6D), confirming the role of
miR-155 in suppressing Socs1 during SEB-mediated activation of immune cells.
2.4 DISCUSSION
With the discovery of miR, a novel and exciting mechanism of gene regulation has
arisen. miRs are small non-coding endogenous RNA molecules that bind 3’ UTR of
genes carrying complimentary sites. A single miR usually targets several mRNA, acting
as a fine-tuner of gene regulation rather than an on-off system (Sonkoly et al., 2009b). In
the context of inflammation, miRs have been found within a variety of immune cells
often targeting genes involved in the regulation of inflammatory response (Lindsay,
2008). In the current study, we closely examined the miR profile after inhalation
exposure to SEB. We observed that amongst the miRs that were dysregulated in response
to SEB, miR-155 was one of the most significantly altered. It has been reported that
naïve CD4+T cells initially display low levels of miR-155, which is increased after the
engagement of TCR by an antigen (Stahl et al., 2009; Thai et al., 2007). This is
consistent with our observation that miR-155 was upregulated following SEB activation.
Recent studies have reported that miR-155-/- mice are resistant to EAE,
demonstrating its importance in mediating disease development (Murugaiyan et al.). In
other studies, miR-155-/- mice failed to control H. pylori infection due to defective Th1
signaling (Oertli et al.). Moreover, in a mouse model of collagen-induced arthritis (CIA),
the deficiency of miR-155 led to a decrease in pathogenic T-cells. In humans, it has also
been reported that soldiers undergoing a battle-field like stress program demonstrated an
increase in hsa-miR-155 levels in leucocytes exposed to SEB ex vivo (Muhie et al.)
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indicating that stress- related inflammation could also potentially lead to the increase in
miR-155. The current study further suggests that the acute inflammatory response in the
lungs to a bacterial superantigen is also regulated by miR-155, inasmuch as, SEBexposed miR-155-/- mice having fewer infiltrating T-cells and almost normal lung
histopathology.
Usually an appropriate regulation of IFN-γ is necessary for mediating Th1
responses and blunting infection (Schoenborn et al., 2007). SEB exposure, however,
causes an excessive release of IFN-γ. T-cells exposed to IFN-γ, proliferate further, thus
perpetuating a cycle of inflammation (Krakauer, ; Lee et al., 1990). Studies carried out
with SEB activation of splenocytes have demonstrated that early cytokines released
include IL-2 and TNF-α, followed by the massive production of IFN-γ by T-helper cells
(Assenmacher et al., 1998). Additionally, in vitro SEB activation of rat splenocytes
results in the release of IFN-γ for up to 48 hours post-activation and promotes the
proliferation of CD4+ T-cells, similar to that seen in mice and humans (Huang et al.,
1998). We have noted in the current model (unpublished) that the peak of acute
inflammatory lung injury occurs at 48 hours after SEB exposure. In line with the typical
kinetics of cytokine release seen with SEB activation, we did not detect early cytokines,
TNF-α and IL-2, in the BALF at this time point (data not shown). However, our data
indicated substantial release of SEB-induced IFN-γ in WT mice suggesting that this
particular cytokine may significantly contribute to SEB-induced inflammation.
Moreover, the correlation between decreased IFN-γ in the BALF of miR-155-/- mice
exposed to SEB and lack of significant inflammation in the lungs is suggestive of a major
role for IFN-γ in our model.
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The relationship between miR-155 and IFN-γ has been briefly explored in
previous studies. For example, when miR-155 is overexpressed in human NK cells, the
subsequent downregulation of a target, SHIP-1, promotes IFN-γ expression (Trotta et
al.). During collagen-induced arthritis, miR-155-/- mice display significantly lower
number of IFN-γ producing cells than WT (Kurowska-Stolarska et al.). Likewise, our
data demonstrated that while transfection with a synthetic miR-155 mimic, leads to the
induction of IFN-γ, the blockade of miR-155, diminishes IFN-γ production. Our results
clearly indicate that the SEB-mediated induction of IFN-γ can be explained, at least in
part, by the induction of miR-155.
To uncover the relationship between miR-155 and IFN-γ in response to SEB exposure,
we employed bioinformatics tools and conducted extensive literature search. These
efforts suggested suppressor of cytokine signaling 1 (SOCS1) as a possible link between
miR-155 and IFN-γ. SOCS1 belongs to a family of eight proteins (SOCS1–SOCS7) that
regulate the production of several cytokines (Krebs et al., 2001). In particular, SOCS1 is
induced by IFN-γ for auto regulation of the IFN-γ pro-inflammatory response by
inhibiting the JAK/STAT1 signaling pathway (Tamiya et al.). Recent experiments in
numerous cell types have revealed that miR-155 targets SOCS1 (Cardoso et al., ; Jiang et
al., ; Zhang et al.). For example, macrophages infected with an RNA virus demonstrated
enhanced Type I interferon production due to miR-155 targeting of Socs1 (Wang et al.).
In the current study we noted that the miR-155-/- mice that are exposed to SEB, showed
increased expression in Socs1 mRNA levels compared to SEB exposed WT mice. The
expression of Socs1 correlated inversely with IFN-γ production in the BALF. In addition,
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our gain and loss of function studies with miR-155 mimic and inhibitor, clearly
demonstrated that miR-155-mediated targeting of Socs1 regulates IFN-γ production.
The results of the present study highlight the role of miR-155 in SEB induced
acute inflammatory lung injury. Specifically, we demonstrate that the high levels of IFNγ production associated with SEB exposure can be attributed to the miR-155 mediated
repression of Socs1, a critical regulator of IFN-γ (Figure2. 7). Furthermore, the
importance of miR-155 is made particularly evident as miR-155 deficient mice were
found to be protected from SEB-mediated inflammation and acute lung injury, thereby
suggesting that therapeutic targeting of miR-155 may be useful in the treatment of SEBtriggered acute inflammatory lung injury.
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Figure 2. 1. SEB induces lung inflammation (A) Representative H&E images (20x) of
cross sections of the lung from mice exposed to either Vehicle or SEB. (B) Lung
infiltrating mononuclear cells obtained by density gradient centrifugation and total
number of viable cells were counted using a hemocytometer. Cells were further stained
with mAb to identify CD4+ and CD8+ cells and analyzed on a flow cytometer. The
percentage of the immune cell subsets was multiplied by the total number of cells found
in the lung and divided by 100 to yield the absolute cell numbers shown. (C) The
concentration of IFN-γ protein present in the BALF was determined using a standard
ELISA kit. Data are mean ± SEM (n=5) and are representative of three independent
experiments. Statistical significance as compared to SEB + Vehicle is indicated as
*p<0.05, ** p<0.01, *** P<0.001, **** p<0.0001.
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Figure 2.2. SEB exposure leads to dysregulation of miRNA. Forty- eight hours after
vehicle or SEB administration, miRNA was isolated from lung infiltrating mononuclear
cells. (A) Heatmap depicting differential expression of miRNA in the lungs of mice
exposed to SEB +vehicle as compared to vehicle. (B) Fold change distribution of the 609
miRNA indicating several upregulated and downregulated miRNA (C) Ingenuity
Pathway analysis generated ‘Top network’ with network function denoted as
‘inflammatory response, cellular development, cellular growth and proliferation’. (D)
Cytoscape generated Gene Ontology (GO) network based on Immunological processes
for the molecules associated in ‘Top Network’ using ClueGo 2.0.7 application. Analysis
criteria consisted of two-sided hypergeometric test with Benjamini Hochberg correction.
Only results with kappa score = 0.3 are displayed. (E) qRT PCR validation of the IPA
generated ‘Top upregulated miRNA’. Total RNA was isolated from lung infiltrating
mononuclear cells. Snord96a was used as the small RNA endogenous control and the
expression level of SEB-induced miRNA shown here was normalized to vehicle. Data is
represented as mean ± SEM from replicate samples (*p<0.05, **p <0.01 as compared to
vehicle).
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Figure 2.3. miR-155 plays a critical role in SEB-induced ALI. WT (C57BL/6) and
miR-155-/- (B6.Cg-Mir155 tm1.1 Rsky/J) mice were exposed to SEB and euthanized 48 hours
later. (A) Representative H&E images (20x) of sections of lung indicating immune cell
infiltration. (B) Phenotypic characterization of cells infiltrating the lung was determined
by staining of mononuclear cells with fluorescent conjugated mAb against CD4 and CD8.
(C) Levels of IFN-γ cytokine in the BALF was determined by ELISA. Data are mean ±
SEM (n=5) and are representative of two independent experiments. Statistical
significance as compared to WT is indicated as *p<0.05, ** p<0.01.
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Figure 2.4. IFN-γ forms a critical link between SEB and subsequent miR-155
induction. (A) Lymph node (LN) T cells obtained from naïve wildtype (WT) mice were
transfected either with miR-155 mimic (Mimic) or mimic control (Control) for 24 hours.
IFN-γ levels were determined by RT-PCR. (B) LN T cells obtained from miR-155-/were also transfected with 10nM miR-155 mimic or mimic control as indicated for 24
hours and IFN-γ levels were assessed. (C) LN cells were activated with SEB (1μg/ml) for
24 hours. Cells were then transfected with 50nM miR-155 inhibitor (Inh) or Inhibitor
Control (Inh Control) for another 24 hours. IFN-γ levels were determined via RT-PCR.
Data is represented as mean ± SEM from replicate samples. Statistical significance is
indicated as *p<0.05, ** p<0.01, *** P<0.001, **** p<0.0001.
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Figure 2.5. Identification of SEB-induced miR-155 targets. (A) miR-155 targets were
filtered based on their role in cytokine signaling, cell growth and proliferation and
cellular immune response using IPA. A proportional Venn diagram indicating the miR155 targets common to all three filtering criteria was generated. The list of targets is
indicated within brackets and Socs1, a highly predicted target is highlighted (red). (B)
IPA network was generated highlighting the highly predicted (yellow) and
experimentally observed (brown) miR-155 targets, in addition to Socs1 (red), the target of
interest. (C) Schematic illustration of the predicted target site for miR-155 within the 3’
UTR of Socs1 mRNA. (D) Total mRNA was isolated from lung-infiltrating mononuclear
cells of WT and miR-155 -/- mice exposed to SEB. Relative expression of Socs1 mRNA
was determined by qRT PCR using β-actin as endogenous control. Data is represented as
mean ± SEM from replicate samples .Statistical significance is indicated as *p<0.05, **
p<0.01, *** P<0.001, **** p<0.0001.
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Figure 2. 6. miR-155 targets Socs1. (A) Chinese Hamster Ovary (CHO) cells were cotransfected with miR-155 mimic or mimic control along with plasmid containing either
the 3’UTR of Socs1 or control plasmid for 24 hours. Relative luciferase activity (firefly
normalized to renilla) was determined following transfection. (B) Lymph nodes (LN)
cells obtained from naïve wildtype (WT) mice were transfected either with 40nM miR155 mimic (Mimic) or mimic control (Control) for 24 hours. Socs1 levels were
determined by RT-PCR. (C) LN cells obtained from miR-155-/- were also transfected
with 40nM miR-155 mimic or mimic control as indicated for 24 hours and Socs1 levels
were assessed. (D) LN cells were activated with SEB (1μg/ml) for 24 hours. Cells were
then transfected with 100nM miR-155 inhibitor (Inh) or Inhibitor Control (Inh Control)
for another 24 hours. Socs1 levels were determined via qRT-PCR. Data is represented as
mean ± SEM from replicate samples statistical significance is indicated as *p<0.05, **
p<0.01, *** P<0.001, **** p<0.0001.
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Figure 2.7. Schematic of SEB-mediated downregulation of Socs1 via miR-155. SEB
exposure leads to the release of IFN-γ and subsequent expression of miR-155. miR-155
mediated suppression of Socs1 prevents appropriate control of IFN-γ leading to cell
proliferation and sustained cytokine signaling and damage to the lung.
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CHAPTER III: Role of miRNA in the Regulation of Inflammatory Genes in
Staphylococcal enterotoxin B-Induced Acute Inflammatory Lung Injury and Mortality.
3.1 INTRODUCTION
Staphylococcus aureus is a commonly occurring gram positive pathogen implicated in a
number of community and nosocomial infections ranging from skin infections,
endocarditis, sepsis and toxic shock (Lowy, 1998). Its pathogenicity can be attributed to a
number of virulence factors such as polysaccharides, proteases, cell surface proteins and
in particular, its ability to secrete potent toxins such as Staphylococcal enterotoxin B
(SEB) (Foster, 2004). Commonly referred to as a superantigen, SEB poses a threat as a
biological weapon because it is effective at smaller quantities, is easily aerosolized and
disseminated. Consequently the Center for Disease Control and Prevention has deemed
SEB, a Category B select agent (Ulrich, 2001).
The consequences of SEB exposure are known to arise from an exaggerated immune
response. Upon directly binding the non-polymorphic regions of the major
histocompatibility complex class II (MHC II) on antigen presenting cells and Vβ8region
of the T-cell receptor, SEB leads to the activation and clonal expansion of ~30-40% Tcells (Kozono et al., 1995). Subsequently, a cytokine storm ensues leading to cellular
infiltration, tissue damage, multi-organ failure and death(Strandberg et al., ; Uchakina et
al.). Although the impact of SEB exposure on key inflammatory signaling pathways
such
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as the NFκB, MAPK has been extensively studied (Krakauer), we have only recently
been made aware of the possible role of microRNA (miRNA) in SEB-mediated
inflammation.
microRNA are a unique class of small (18-25 nucleotides), single-stranded non-coding
RNA molecules that have emerged as primary regulators of gene expression(Dai et al., ;
Davidson-Moncada et al.). Mammalian miRNA bind primarily to the 3’ UTR of their
respective target mRNA causing mRNA instability and degradation and/or the disruption
of translation (Davidson-Moncada et al.). Although miRNAs are involved in the
development and differentiation of cells, apoptosis and hematopoiesis under normal
conditions, inflammatory cues leads to their dysregulation, thereby enabling the targeting
of key regulators of inflammation (O'Connell et al., 2010; Sonkoly et al., 2008). For
example, in rheumatoid arthritis, the overexpression of miR-146a in CD4+ T-cells
obtained from the synovial fluid is associated with increased expression of TNFα (Li et
al.). Similarly, the inhibition of miR-126 in a house dust mite induced model of asthma,
leads to the decrease in allergic inflammation (Mattes et al., 2009) . Conversely, while
high levels of miR-125b are required to maintain a naïve state of T-cells, the activation of
T-cells leads to its downregulation and subsequent expression of its target gene, Ifng
(Rossi et al.).
Recently, our laboratory has demonstrated that intranasal exposure to SEB in C57BL/6
mice leads to the strong dysregulation of miRNA. miR-155 in particular promotes SEBmediated acute inflammatory lung injury(Rao et al.). In the current study, we
administered SEB as a ‘Dual Hit’ to C3H/HeJ mice which entails administering small
quantities (5μg and 2 μg) of SEB intranasally and intraperitoneally respectively, two
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hours apart that results in the hyperactivation of the immune system and 100% mortality
of mice. Upon investigating the effect of SEB exposure on the miRNA profile, we
observed the aberrant expression of several miRNA that could potentially contribute to
SEB-mediated inflammation. Further, applying bioinformatics tools and q-RT PCR, we
established important links between the miRNA and their respective target genes. Using
gain -and -loss of function experiments we specifically demonstrate the possible role of
miR-132 in mediating damage and death. Thus, our results provide further insights into
the role of SEB-induced miRNA in contributing towards severe acute inflammatory lung
injury and consequent mortality.
3.2 MATERIALS AND METHODS
Mice
Female C3H/HeJ mice (6-8 weeks) were obtained from the Jackson Laboratory. All mice
were housed under pathogen free conditions in the Animal Resource facility (ARF),
University of South Carolina, School of Medicine. All experiments using vertebrate
animals were performed under protocols approved by the Institutional Animal Care and
Use Committee (IACUC) at USC.
Administration of SEB
SEB was acquired from Toxin Technologies (Sarasota, FL). SEB was administered as a
‘Dual- Hit’ as described previously (Huzella et al., 2009). The first dose of SEB was
delivered by the intranasal (i.n) route at a concentration of 5 μg /mouse in a 25 μl volume.
Two hours after, the second dose of SEB was administered intraperitoneally (i.p) at a
concentration of 2 μg/mouse in a 100 μl volume. Control mice were similarly given PBS
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(vehicle) as a dual dose. While mice were euthanized 72 hours after SEB exposure in all
experiments, survival of mice was monitored up to 5 days after exposure to SEB and any
moribund mice were immediately euthanized.
Lung Histopathology
72 hours after exposure to either Vehicle or SEB, lungs were excised and fixed in 10%
formalin. Lung tissue was paraffin embedded and 5μm serial sections were made.
Subsequently, the sections were deparaffinized by dissolving in xylene, rehydrated in
alcohol (100%, 95%, and 90%). The sections were stained with hematoxylin and eosin
(H&E) and assessed with Nikon E600 light microscope. Images were taken at 40X
magnification.
Assessment of Vascular Leak
The percent of Vascular leakage in the lungs was determined as described previously
(Rieder et al., ; Saeed et al.). Briefly, 72 hours after Vehicle or SEB exposure, mice were
administered 1% Evans Blue dye in sterile PBS intravenously (i.v). Two hours later, the
mice were euthanized and lungs perfused with heparinized PBS. The lungs were
incubated in formamide at 37 ° C for 24 hours to extract the dye. The optical density
(O.D) of the supernatant was measured by a spectrophotometer at 620 nm. Percent
increase in Vascular Leak was calculated using the following formula - (O.D sample- O.D
control/O.D control)

x 100.

Preparation of lung infiltrating cells
72 hours after exposure to Vehicle or SEB, lungs were perfused with heparinized PBS
and harvested. They were then homogenized using Stomacher 80 Biomaster blender from
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Seward (Davie, FL) in 10 ml sterile PBS. Following washing with sterile PBS, the cells
were separated by density gradient centrifugation at 500 x g for thirty minutes at 24 °C
with the brake off. Mononuclear cell layer isolated was enumerated by the Trypan blue
exclusion method using a hemocytometer.
Detection of Cytokines
Cytokines in the Broncheoalveolar lavage fluid (BALF) were obtained as described
previously (Rao et al.). Briefly, 72 hours after Vehicle or SEB exposure, mice were
euthanized. The trachea was bound with a suture and the lung was excised as an intact
unit along with the bound trachea. Sterile ice-cold PBS was injected through the trachea
to collect the BALF. Cytokine detection was carried out using Bio-Plex Pro ™ mouse
cytokine 23-plex Assay from Biorad (Hercules, CA).
In vitro Assays
Splenocytes from naïve C3H/HeJ mice were harvested and cultured in complete RPMI
(10% FBS, 10mM L-glutamine, 10mM Hepes, 50 μM β-Mercaptoethanol, and 100
μg/mL penicillin). Cells were seeded at a density of 1x106 cells in a 96 well plate and
stimulated with either PBS (Vehicle) or SEB (1 μg/ ml) for 24 hours. The cells were then
harvested to examine CD4, Vβ8 percentages or activation markers- CD69, CD28,
CD62L, and CD86. Cellular proliferation was measured by similarly seeding and
activating splenocytes for 48 hours. In the last twelve hours of incubation, 3[H]Thymidine (2μCi) was added to the cell culture. Cells were then collected using a
harvester and thymidine incorporation was measured using a scintillation counter (Perkin
Elmer).
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Flow Cytometry and Antibodies
To determine the phenotypic characteristics of the lung infiltrating mononuclear cells and
splenocytes obtained from in vitro cell culture assay above, cells were stained with the
following fluorescent conjugated antibodies - Fluorescein isothiocyanate (FITC) conjugated anti-CD8 (clone: 53-6.7), Phycoerthyrin (PE)-conjugated anti-CD4 (clone:
GK 1.5), FITC-conjugated anti-CD69 (clone : H1.2F3), PE-Cy5-conjugated anti-CD28
(clone 37.51), PE-conjugated anti-CD62L (clone MEL-14), PE-conjugated anti-CD86
(clone Gl-1) from Biolegend (San Diego, CA) and (FITC-conjugated anti-Vβ8 (clone:
K516) from Ebioscience (San Diego, CA). Stained cells were run and analyzed using
Beckman Coulter 500 Flow Cytometer (Indianapolis, IN).
Total RNA extraction
Total RNA (including small RNA) was isolated from lung infiltrating mononuclear cells
using the miRNAeasy kit from Qiagen (Valencia, CA) according to manufacturer’s
instructions. The purity and concentration of total RNA was confirmed
spectrophotometrically by Nanodrop 2000c from Thermo Scientific (Wilmington, DE).
The integrity of miRNA was further confirmed using Agilent 2100 BioAnalyzer (Agilent
Tech, Palo Alto, CA).
miRNA expression profiling
To profile the miRNA expression in the lung after SEB exposure, the Affymetrix
GeneChip® miRNA 3.0 array platform was used. The array identified 1111 mouse
miRNA derived from the Sanger miRBase v17 (www.mirbase.org). Total RNA was
labeled with Flash Tag ™ Biotin HSR labeling kit from Affymetrix (Santa Clara, CA)
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according to manufacturer’s instructions. Briefly, RNA spike control Oligos were added
to the RNA and incubated with a Poly A Tailing master mix for 15 min. Next, the RNA
was labeled with Biotin using FlashTag ™ Biotin HSR Ligation mix. For hybridization
of the biotin-labeled samples to the array, a GeneChip ® Eukaryotic Hybridization
Control kit comprising of bioB, bioC, bioD and cre was used to create the array
hybridization cocktail. Following incubation at 99 °C for 5 min, then 45 °C for 5 min, a
small volume (100 μl ) was injected into an array. The arrays were further incubated at
48°C and 60 rpm for 16-18 hours. Post-hybridization, the array was washed and stained
with fluorescent-conjugated streptavidin using the Fluidics Station 450. The stained chip
was scanned on a GeneChip Scanner (Affymetrix) to generate the data summarization,
normalization and quality control files. All microRNA microarray data was deposited
into ArrayExpress database (www.ebi.ac.uk/arrayexpress/) under the ArrayExpress
accession number E-MTAB-2641.
miRNA and mRNA target gene analysis
The fluorescent intensities obtained from the hybridization were log transformed, mean
centered and visualized as a heatmap. Hierarchical clustering was carried out using
Ward’s method and similarity measurement was calculated using half square Euclidean
distance. miRNA fold change differences between Vehicle and SEB as obtained from the
microarray was plotted as a fold change distribution plot. Further, only miRNA that
showed > 2 fold higher or lower values in SEB exposed lung infiltrating cells compared
to control were considered for analysis. Proportional Venn diagram was created using
Venn Diagram Plotter (http://omics.pnl.gov/software/venn-diagram-plotter). To further
assess the biological functions and visualize miRNA interactions with its respective
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target genes associated with the miRNA, we employed the use of the commercially
available tool Ingenuity Systems, Ingenuity Pathway analysis (IPA) (Mountain View,
CA). Additionally, to assign immunological functions to miRNA target genes, we used
Cytoscape 3.0.1, an open source tool equipped with the Gene Ontology applications,
ClueGO and CluePedia.
Real Time qPCR
Total RNA (miRNA and mRNA) obtained from lung infiltrating mononuclear cells or in
vitro from splenocytes was converted to cDNA using miSript cDNA synthesis kit
(Qiagen) according to manufacturer’s instructions. To validate and detect miRNA, qPCR
was carried out using miScript primer assays (miR-132, miR-155, miR-31, miR-222,
miR-20b, let-7e, miR-192, miR-193*, miR-34a and control Snord96_a) that employs
SYBR Green technology from Qiagen. Fold change was determined using the 2 ΔΔCt
method and expressed relative to control. For mRNA validation, SSO advanced SYBR
green PCR kit from Biorad (Hercules, CA) was used according to manufacturer’s
instructions. β-actin was used as the internal control. Primers (Table 3.1) were
synthesized from Integrated DNA technologies (IDT).
Transfection with miR-132 mimic and inhibitor
Splenocytes from naïve C3H/HeJ mice were harvested and cultured in 10 ml of complete
RPMI. Cells were seeded at 2 X 105 cells per well in 24 well plates and transfected with
synthetic miR-132 mimic (40 nM) or mock transfected with Transfection reagent
HiperFect from Qiagen for 24 hours. For miR-132 inhibition, cells were activated with
SEB (1μg/ml) and transfected with either mock control or miR-132 inhibitor also
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purchased from Qiagen. 24 hours after transfection, total RNA was collected for qRT
PCR validation of miR-132 and target gene Foxo3.
Statistics
All statistical analyses were carried out using GraphPad Prism Software (San Diego,
CA). In all experiments, the number of mice used was 4-5 per group, unless otherwise
specified. Results are expressed as means ± SEM. Student’s t-test was used to compare
two-groups. A p-value of < 0.5 was considered statistically significant. Individual
experiments were performed in triplicate and each experiment was performed
independently at least three times to test reproducibility of results. Survival analysis was
carried out using a Log-rank test.
3.3 RESULTS
SEB exposure leads to lung inflammation and acute mortality
The ‘Dual Hit’ model of SEB administration has been previously known to result in
severe inflammation in the lungs and death of the mice (Huzella et al., 2009). In this
study, we found that SEB administration resulted in 100% mortality in mice between 96
and 120 hours (Figure 3.1A) when compared to mice exposed to vehicle. Pulmonary
damage was characterized by the disruption of lung integrity, vascular leak and
consequently edema. To quantitate the extent of damage to the lungs after SEB exposure,
mice were administered Evans blue dye and vascular leak expressed as a percent increase
over vehicle as described earlier (Rieder et al., ; Saeed et al.) . Our results revealed that
SEB exposure had almost an eight fold increase in vascular permeability compared to
mice that were only exposed to vehicle (Figure 3.1B). Further, a consequence of SEB
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exposure is the infiltration of immune cells around air vessels and bronchioles (Rao et
al., ; Rieder et al.). Accordingly, histopathological examination of the lungs confirmed
the presence infiltrating immune cells after SEB exposure compared to vehicle alone
(Figure 3.1C). Further, upon enumeration of the total number of infiltrating mononuclear
cells in the lung, we found a profound increase in the number of cells post-SEB exposure
compared to vehicle (Figure 3.1D). Because SEB exposure leads primarily to the clonal
expansion of Vβ8+ T-cells, we further assessed the immune subsets (CD4, CD8 and Vβ8)
by staining with fluorescein-conjugated antibodies and analyzed using flow cytometry.
As expected, we found significantly increased absolute cell counts in all three subsets
after SEB exposure (Figure 3.1E).
SEB, being a superantigen is known to result in the massive release of cytokines.
Therefore, we obtained the broncheoalveolar lavage fluid (BALF) from mice that were
exposed to vehicle or SEB and screened for several cytokines and chemokines such as
IFN-γ, IL-6, IL-12, IL-1α, MCP-1, MIP-1, G-CSF, Eotaxin and KC (Figure 3.2) and
found that SEB triggered significant levels of these mediators.
SEB exposure leads to the activation and proliferation of immune cells in vitro
To determine if SEB exposure can trigger activation of specific immune cell subsets, we
exposed splenocytes with SEB in vitro for 24 hours and assessed activation by flow
cytometry. Compared to vehicle, SEB lead to increased proportions of T-cell activation
markers: Vβ8, CD28, CD69 and CD86 (Figure 3.3A). While we had earlier demonstrated
that SEB administration leads to increased cell counts in the lung, we investigated if
activation of splenocytes with SEB, could also lead to increased cellular proliferation.
Indeed, activation with SEB for 48 hours resulted in significantly higher thymidine
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counts as compared to vehicle (Figure 3.3B). Cellular proliferation and activation,
especially of T-cells, is influenced by IL-2 production. Consequently we found
exaggerated levels of IL-2 in the supernatants of cells activated with SEB. Similarly,
IFN-γ, a hallmark cytokine associated with SEB exposure was measured and high
concentrations (~2500 pg) was found upon SEB exposure (Figure 3.3C). These data
indicate that SEB triggers the activation and proliferation of cells, in vitro in addition to
in vivo.
SEB exposure results in the dysregulation of several microRNA
While miRNA are known to be induced during inflammation and play a critical role in its
regulation, expression profile of miRNA during SEB-mediated lung inflammation and
consequent death has not yet been investigated. Therefore, we extracted total RNA from
the lung infiltrating mononuclear cells from mice that were either exposed to vehicle or
SEB and performed miRNA microarray. The heatmap revealed a noticeable difference in
fold change between vehicle and SEB-treated groups (Figure 3.4A). To visualize the
distribution of the miRNA, a radial fold change distribution plot was generated
demonstrating that while most miRNA remained unchanged and were found around the
circumference of the plot, a few miRNA were highly upregulated ( up to 56 fold) or
highly downregulated (up to 22 fold) when compared to vehicle (Figure 3.4B). Amongst
the miRNA assessed on the array, approximately 4% of the miRNA were either
overexpressed or underexpressed greater than and equal to two-fold in SEB exposed cells
compared to vehicle (Figure 3.4C). Next, Ingenuity Pathway analysis (IPA) was
employed to analyze on this fraction of dysregulated miR, which yielded a list of top
upregulated (miR-132, miR-155, miR-31, miR-20b, miR-222) and downregulated miRs
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(miR-192, miR-193*, let -7e, miR-34a), whose fold change values as determined by the
microarray, seed sequence and miRbase accession numbers were tabulated (Table 2).
Next, the miRNA expression levels in the lung infiltrating mononuclear cells were
validated by q-RT PCR. These results corroborated the expression pattern observed with
the microarray (Figure 3.5).
Functional analysis of the dysregulated miRNA
To examine the possible biological functions associated with the over and
underexpressed validated miRNA, IPA core analysis was conducted and statistically
significant (Fishers exact test) biological functions were generated and -log [p-value] was
plotted as a bar graph. We observed that cellular development, cell death and survival,
cellular growth and proliferation, cell cycle, cell-cell signaling and interaction and gene
expression were highly enriched functions associated with the SEB-mediated alterations
in the miRNA (Figure 3.6A). A further dissection of these biological functions revealed
that a majority of the molecules closely associated with the dysregulated miRs, were
involved in very specific functions. For example, almost half of the molecules linked
with cellular development were involved in the differentiation of mononuclear leukocytes
and T-lymphocytes. Further, a vast majority (~45%) of the molecules associated with
cellular growth and proliferation were linked specifically to propagation of Tlymphocytes. Similarly, cell-cell signaling and interactions predominantly comprised of
the specific activation of T-lymphocytes and T-cell responses (Figure 3.6B),
characteristic features of SEB-induced inflammation. Thus, our results suggested that the
miRNA expression profile and its associated biological functions, as indicated in silico,
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correlated with experimentally observed lung inflammation accompanying SEB
exposure.
Predicted mRNA targets of the dysregulated miR after SEB exposure
Next, we identified possible miR targets by employing IPA. Highly predicted,
experimentally observed as well as moderately predicted targets of the validated miRNA
were filtered using the miRNA target filter tool. Only those molecules that were
associated with the inflammatory process were considered for analysis. Amongst these
target genes, we found that the upregulated miRNA were predicted or experimentally
observed to target transcription factors and genes involved in the regulation of
inflammation. For example, miR-132 and miR-155 targeted B-Cell CLL/Lymphoma 10
(BCL10), an inducer of apoptosis. Similarly, miR-20b and miR-222 target the suppressor
of cytokine signaling (Socs) genes, which are negative regulators of several proinflammatory cytokines (Table 3.3). In contrast, the downregulated miRNA such as let 7e, miR-34a, miR-192 and miR-193* were predicted to target pro-inflammatory molecules
such as those involved in cellular proliferation, activation and cytokine production (Table
3.3). IPA pathway designer tool was also used to visualize the miRNA-mRNA
interactions (Figure 3.7A) which provided further insight into how the over and
underexpressed miRNA target key molecules and collectively act to regulate
inflammation. Finally, to confirm the immunological functions of the miRNA target
genes, Gene Ontology (GO) tool, ClueGo, was employed which yielded a map of highly
enriched GO terms (Figure 3.7B) such as Lymphocyte activation (GO:0046649) ,
Positive regulation of lymphocyte activation (GO:0051251), Regulation of T-cell
activation (GO:0050863) and Positive regulation of immune effector process
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(GO:0002699). Together, these data indicated a strong role for key miRNA, induced by
SEB, in the regulation of lung inflammation.
Experimental validation of mRNA target genes.
To validate and confirm some of the predicted target genes, q-RT PCR was carried out
using mRNA from lung infiltrating mononuclear cells following exposure to vehicle or
SEB. Interestingly, upon using microRNA.org (www.microRNA.org) miRNA-mRNA
alignment tool, we observed that a few of the upregulated miRNA, aligned to the 3’ UTR
of some of these target genes. For example, miR-155, miR-132, miR-31 bind Smad3,
while miR-20b and miR-222 aligned to the 3’UTR of Runx1. miR-132, which was highly
induced following SEB exposure, aligned with the 3’UTR of Foxo3, with the potential to
target it (Figure 3.8A). We observed significant downregulation of Smad family member
3 (Smad3), Transforming Growth Factor, Beta 1 (Tgfβ1), Forkhead box O3 (Foxo3) and
runt-related transcription factor 1 (Runx1) (Figure 3.8B), molecules that have been
experimentally shown to regulate cellular proliferation, cell cycle progression and
cytokine production when induced. Further, the microRNA.org tool suggested that a few
underexpressed validated miRNA i.e., miR-192, miR-34a and let-7e aligned to the
3’UTR of these genes (Figure 3.8C) while several genes associated with the proinflammatory pathway such as T-box 21(Tbx21), signal transducer and activation of
transcription 3 (Stat3), prostaglandin-endoperoxidase synthase 2 (Ptgs2), nuclear factor
kappa (Nfκb) and cell cycle progression genes such as Cyclin D1(Ccnd1) and Cyclin
E1(Ccne1) were induced upon SEB exposure (Figure 3.8D). Altogether, our results
indicated that SEB causes alterations in the expression profiles of a significant number of
miRNA, which in turn may either allow for the expression of pro-inflammatory genes or
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lead to the degradation of anti-inflammatory molecules, thereby collectively contributing
to severe lung inflammation.
miR-132 targets Foxo3, an inhibitor of cellular proliferation and cell cycle progression
miRNA microarray analysis demonstrated that miR-132 was the most highly induced
after SEB exposure (Table 3.2). Therefore, we rationalized that miR-132 may play a
prominent role in mediating inflammation and damage in the current model.
Additionally, amongst the many miR-132 predicted target genes, transcriptional factor
Foxo3, was especially interesting not only because of its observed role in inhibiting
cellular proliferation and curbing cell cycle progression, but due to the fact that miR-132
aligned to the 3’UTR of Foxo3. To confirm the binding of miR-132 to Foxo3, we
transfected splenocytes with a miR-132 synthetic mimic. While the levels of miR-132
were highly increased with the mimic, Foxo3 levels inversely correlated with its
expression (Figure 3.9A). Similarly, SEB activation of splenocytes led to the expected
increase in miR-132, but the inhibition of miR-132 resulted in the de-repression of Foxo3
(Figure 3.9B). These results suggested that miR-132 targets Foxo3, thereby preventing
the regulation of cellular proliferation seen upon SEB exposure.

3.4 DISCUSSION
The recent discovery of microRNA (miRNA) has propelled our understanding of gene
regulation. These non-coding, evolutionarily conserved RNA molecules function
primarily as repressors of gene expression and are estimated to regulate approximately
30% of all human genes (Lewis et al., 2005). While the role of miRNA in mammalian
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cells was first brought to the forefront in cancer (Calin et al., 2002), their importance in a
number of immune cell activation and functions has since been stressed (Baltimore et al.,
2008). With regards to inflammation, several changes in the transcriptional repertoire are
accompanied with perturbation in miRNA(O'Connell et al., 2010). As a result, it is
conceivable that miRNA control several aspects of the inflammatory process.
In the current study, we have profiled the miRNA expression patterns following exposure
to SEB. Using in silico analysis and q-RT PCR approaches we identified several miRNA
that were altered in response to SEB. Importantly, these miRNA were found to be closely
associated with key genes either involved in the control of inflammation or those that
contributed directly to SEB-mediated inflammatory processes. By showcasing the effects
of specific over and underexpressed miRNA, we provide evidence that the outcome of
SEB exposure such as severe lung inflammation and death of mice can be explained, at
least in part, to the intricate miRNA alterations and miRNA-mRNA interactions.
Following the unconventional binding of SEB to the major histocompatibility complex
(MHC) class II on antigen presenting cells (APCs) and subsequent activation of Vβ8
region of the T-cell receptor, the immune system gets hyperactivated due to the presence
of large proportions (~30% ) of Vβ+T cells (Krakauer). As a consequence, such T-cells
get clonally expanded resulting in a cytokine storm (Rajagopalan et al., 2006). Although
several murine models have been developed to study the toxic effects of SEB (Krakauer
et al.), very few models exhibit mortality in the absence of the use of additional
potentiating agents such as D-gal or LPS to mimic the consequence of exposure to the
toxin in humans (Miethke et al., 1992; Savransky et al., 2003). The dual administration
of SEB while addressing this concern, has previously been reported to result in severe
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lung inflammation and the subsequent death of mice (Huzella et al., 2009). In line with
this previous observation, we found dual exposure to SEB, resulted in extensive
inflammation of the lung characterized by immune cell infiltration, accumulation of
cytokine and chemokines in the BALF, compromised lung function and eventually the
mortality of mice.
Previously, we studied the effect of a single high dose (50 μg) administration of SEB
intranasally in C57BL/6 mice and studied lung inflammation (Rao et al.). In this model,
although mice exhibit symptoms of acute inflammatory lung injury, there is no mortality
seen in mice exposed to SEB. Nonetheless, we demonstrated the predominant role of
miR-155 in mediating acute inflammatory lung injury in this model (Rao et al.). The
current “dual-hit” model, because of smaller quantities of SEB, and high mortality, is
more relevant to SEB exposure in humans. It is for this reason that we aimed to highlight
the miRNA profile after acute SEB exposure in this model. While we also observe the
induction of miR-155 in the current model, we see a similar upregulation of other
miRNA such as miR-31, miR-20b, miR-222 and miR-132 and the significant
downregulation of miRNA such as let-7e, miR-34a, miR-192 and miR-193*.
Interestingly, the expression of these miRNA has been associated with a variety of
inflammatory conditions suggesting that they may collectively act to orchestrate the
severe inflammation observed after SEB exposure. For example, miR-31 is
overexpressed in psoriasis skin and mediates its pro-inflammatory role by targeting
STK40, a negative regulator of NFκB (Xu et al.). Similarly, miR-155 expression
correlates positively with that of NFκB activation in Heliobacter pylori infection and in a
murine model of chronic alcohol consumption and inflammation (Bala et al., ; Xiao et al.,
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2009). Given that SEB exposure is known to activate the NFκB signaling pathway
(Kissner et al.) and cause the expression of pro-inflammatory cytokines, as indicated by
our results, it is possible that specific SEB-induced miRNA may function via the
activation of NFkB.
Related to the expression of NFkB is the SEB-induced activation of the STAT family of
proteins, especially STAT3 (Plaza et al., 2004). Activated by cytokines such as IL-6, the
STAT3 molecule, along with NFκB leads to cellular proliferation, cell survival, cytokine
production and immune cell activation (Yu et al., 2009), key inflammatory pathways we
observed experimentally in this study. In addition to finding an increase in Stat3 mRNA
levels after SEB exposure, we demonstrate that miR-let7e, miR-34a and miR-193* that
are predicted to target STAT3 are significantly downregulated, thereby facilitating its
expression.
Previous reports indicated that the overexpression of miR-34a and miR-193* leads to cell
cycle arrest and repression of cellular proliferation by the targeting of CCND1 (Chen et
al., ; Sun et al., 2008). Similarly, while miR-192 is predicted to target CCNE1, let-7e has
been experimentally validated to directly degrade it in hepatocellular carcinoma cells
(Zhang et al.). Because these miRNA were specifically downregulated upon SEB
activation, we observed the unrestrained expression of Ccnd1 and Ccne1 suggesting that
the significant downregulation of these miRNA may contribute to cell cycle progression
and cellular proliferation.
Consistent with previous studies (Busbee et al., ; Green et al., 1992), we have
demonstrated that SEB exposure predominantly affects T-cells, leading to their activation
(as indicated by assessment of activation markers) or their recruitment into the lung in
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large numbers. Interestingly, our in silico analysis of dysregulated miRNA and its target
genes primarily highlighted a number of T-cell specific functions, such as those that
promote T-cell activation and proliferation. Of interest, Runx1, a transcriptional factor
that drives various aspects of T-cell activation and differentiation was highlighted by our
analysis. Functionally, Runx1 levels remain high in naïve CD4+ T-cells but the activation
of T-cells turns off its expression (Wong et al.). Moreover, Runx1 deficiency leads to Tcell proliferation and the induction of IL-2 (Wong et al.). We observed that the SEBinduced down regulation of Runx1 corresponded inversely with the induction of miR-20b
and miR-222, miRNA that are specifically predicted to bind the 3’UTR of Runx1,
suggesting that these miRNA may contribute to SEB-mediated T-cell proliferation and
activation.
Comparable to the role of Runx1 in activated CD4+T-cells, the impairment of the
TGFβ/SMAD3 pathway, also leads to the activation and proliferation of T-cells (Delisle
et al.). Furthermore, TGFβ mediated cellular apoptosis and cell cycle arrest is known to
occur through the activation of SMAD3 (Ten Dijke et al., 2002) . Our data demonstrated
a strong downregulation of Smad3 and Tgfβ mRNA levels. Interestingly, three of the
most highly overexpressed miRNA i.e. miR-132, miR-155 and miR-31 were predicted to
align to the 3’UTR of Smad3, strongly suggesting a role of these miRNA in this pathway.
It is striking that the microarray results revealed a very high expression of miR-132,
which was validated by q-RT-PCR. Although expressed in high levels in the brain with
the capacity to influence neuronal differentiation and synaptic plasticity(Lungu et al., ;
Scott et al.), very few studies have explored its role in inflammation. In primary human
preadipocytes, the overexpression of miR-132 results in the targeting of SIRT-1, the
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subsequent activation of NFkB and induction of MCP-1 (Strum et al., 2009). Following
CD4+ T-cell activation, the overexpression of miR-132 facilitates HIV-1 replication
(Chiang et al.). Because we witnessed the activation of CD4+ T-cells and the production
of MCP-1 after SEB exposure, it is reasonable to believe that miR-132 may influence
these immune processes. Moreover, the in silico analysis of the target genes pertaining to
inflammation revealed that miR-132 could moderately target Bcl10 and Tgfb2, but was
highly predicted to target Smad2, Smad5 and the Foxo set of transcriptional factors ,
especially Foxo3. It is known that FOXO3 overexpression leads to apoptosis and that one
of its primary functions is to regulate unprecedented cellular proliferation (Hedrick et
al.). Moreover, the absence of FOXO3 leads to hyperactivation of T-cells, autoimmunity
and lymphoadenopathy (Lin et al., 2004). Prompted by the importance of FOXO3 in
controlling inflammation, we pursued the gain- and - loss of function experiments with
synthetic miRNA mimic and inhibitors and found an inverse relationship between miR132 and Foxo3. These data suggested that the targeting of Foxo3 by the highly expressed
miR-132 could offer an explanation for uninhibited cellular proliferation, the expression
of cell cycle progression genes and the production of a number of cytokines and
chemokines in response to SEB.
In summary, we have effectively profiled several miRNA following exposure to the
superantigen, SEB. Our data revealed that SEB significantly altered the expression of
miRNA predicted to have pro-inflammatory roles. With the consequence of SEB
exposure being extensive lung inflammation and acute mortality of mice it is likely that
several miRNA are acting in concert to enhance the severity of the disease. Additionally,
since miRNA have several co-targets, its impact would be expected to be widespread and
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involve the simultaneous activation and cross talk of a number of inflammatory signaling
pathways as highlighted in the study. To the best of our knowledge, we are the first to
report the differential regulation of miRNA in response to SEB in a murine model of
acute inflammatory lung injury. While it would be interesting to identify a principal
miRNA, the inhibition of which rescues mice from SEB-induced toxicity our results
nevertheless point towards the potential therapeutic modulation of miRNA to mitigate
SEB-induced toxicity.
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Table 3.1. Real time qPCR primer list
Gene
Tbx21

Sequence 5’→3’
AAC CGC TTA TAT GTC CAC
CCA
CTT GTT GTT GGT GAG CTT
TAG C
CCA CCT GCA AGA CCA TCG
AC
CTG GCG AGC CTT AGT TTG
GAC
GCA AGC CGT GTA CTG TGG A
CGG GAG CGC GAT GTT ATC C
AAT ATA GCC GAT TCC TGC
AGA G
TGG CTT CTC AAG ATA CCT
GCT C
ATG GCA GAC GAT GAT CCC
TAC
TGT TGA CAG TGG TAT TTC
TGG TG
GCG TAC CCT GAC ACC AAT
CTC
ACT TGA AGT AAG ATA CGG
AGG GC
GTG GCT CCG ACC TTT CAG
TC
CAC AGT CTT GTC AAT CTT
GGC A
TGA GCA ACT ATT CCA AAC
CAG C
GCA CGT AGT CTT CGA TCA
CTA TC
AGG GGC TCC CTC ACG TTA
TC
CAT GGC CCG TAA TTC ATG
GTG
GCA GGC AAC GAT GAA AAC
TAC T
GCA ACT TGT GGC GGA TTT
GTA
GGC TGT ATT CCC CTC CAT
CG
CCA GTT GGT AAC AAT GCC
ATG T

Primer
Tbx21-F
Tbx21-R

Tgfb1

Tgfb1-F
Tgfb1-R

Foxo3
Stat3

Foxo3-F
Foxo3-R
Stat3-F
Stat3-R

Nfκb

Nfκb --F
Nfκb-R

Ccnd1

Ccnd1-F
Ccnd1-R

CcnE1

CcnE1-F
CcnE1-R

Cox2

Cox2-F
Cox2-R

Smad3

Smad3-F
Smad3-R

Runx1

Runx1-F
Runx1-R

β-actin

β-actin -F
β-actin -R
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Table 3.2.List of select differentially expressed (> 2 fold) miRNA in lung infiltrating
mononuclear cells after SEB exposure compared to Vehicle control.

miRNA

Fold change

Seed Sequence

Accession
number

mmu-miR-132

56.7

AACAGUC

MIMAT0000144

mmu-miR-155

38.8

UAAUGCU

MIMAT0000165

mmu-miR-31

15.2

GGCAAGA

MIMAT0000538

mmu-miR-20b

5.6

AAAGUGC

MIMAT0003187

mmu-miR-222

3.4

GCUACAU

MIMAT0000670

mmu-miR-193*

-22.3

GGGUCUU

MIMAT0004544

mmu-miR-192

-10.6

UGACCUA

MIMAT0000517

mmu-let-7e

-8.5

GAGGUAG

MIMAT0000524

mmu-miR-34a

-6.2

GGCAGUG

MIMAT0000542

Overexpressed

Underexpressed
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Table 3.3. List of predicted or experimentally observed miRNA target genes associated
with inflammation.
miRNA
miR-132

↑

Target genes
Foxo1, Foxo3, Tgfb2, Bcl10, Smad2,
Smad5

miR-155

↑

Bcl10, Foxo3, Socs1, Smad2,

miR-20b

↑

Runx1, Mcl1, Pten, Socs6, Socs7, Tgfbr2

miR-222

↑

Foxo3, Gata4, Pten, Socs1, Socs3

miR-31

↑

Foxp3, Smad3, Rorc

let7e

↓

Ccnd1, Ccne1 Cd80, Cd86, Cdkn1a, Il6,
Il6r, Stat3

miR-192

↓

Nfat5, Cxcr5, Traf5, Traf6,Zeb1,Ccne1

miR-193* ↓

Ccnd1, Ets1, Esr1, Il12rg, Cd247, Ptgs2

miR-34a ↓

Ccnd1,Bcl2, Il6r, Il2rb, Map2k1, Pik3r2
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Figure 3.1. SEB exposure results in pulmonary inflammation and mortality of mice.
C3H/HeJ mice were exposed to a ‘Dual Hit’ of SEB and euthanized 72 hours post
exposure. (A) Survival curve of mice exposed to either vehicle or SEB. (B) Measurement
of Vascular Leak 24 hours after exposure to the second dose of SEB. Mice were
administered Evans blue dye and following perfusion, lungs were placed in formamide.
Absorbance was recorded at 620 nm and the percentage of vascular leak was calculated
and graphically represented. (C) Representative H&E (x 40) staining of sections of the
lung demonstrating immune cell infiltration. (D) Total number of mononuclear cells
infiltrating the lungs in vehicle or SEB exposed mice as determined by trypan blue
exclusion method. (E) Phenotypic characterization of mononuclear cells infiltrating the
lung determined by staining cells with fluorescein-conjugated antibodies against CD4,
CD8 and Vβ8 and conducting flow cytometric analysis. Absolute cell counts are
represented graphically. Data are means ±SEM (n=5) and are representative of three
independent experiments. Statistical significance is indicated as follows *p<0.05, **
p<0.01, *** P<0.001, **** p<0.0001 (as compared to vehicle).
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Figure 3.2. Exaggerated expression of chemokines and cytokines after SEB
exposure. Mice were exposed to either vehicle or SEB for 72 hours and euthanized. The
trachea was bound with a suture. Following the excision of the lung along with the
trachea, 1 ml of ice-cold PBS was flushed through the trachea and collected as the
Broncheoalveolar lavage fluid (BALF). Cytokine and chemokine expression was
analyzed using a Bioplex and the concentration quantified in pg/ml. Data are means
±SEM (n=5) and are representative of three independent experiments. Data are means
±SEM (n=5) and are representative of two independent experiments. Statistical
significance is indicated as follows *p<0.05, ** p<0.01, *** P<0.001, (as compared to
vehicle).
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Figure 3.3. Effect of SEB activation in vitro. Splenocytes seeded at a density of 1X10 6
cells were activated with 1 μg/ml of SEB. (A) Twenty four hours after activation, cells
were harvested and stained with fluorescein-conjugated antibodies against Vβ8 and
activation markers CD69, CD86 and CD28. The representative histograms are depicted
(B) Cell proliferation assay as measured by the incorporation of thymidine in splenocytes
that were activated with SEB for forty-eight hours. (C) Cytokine expression determined
by ELISA. Samples were obtained from collecting the supernatants following SEB
activation of splenocytes. For all experiments cells were plated in triplicates and data is
representative of two independent experiments. Statistical significance is indicated as
follows ** p<0.01, *** P<0.001, **** p<0.0001 (as compared to vehicle).
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Figure 3. 4. SEB exposure leads to dysregulation of microRNA. Seventy-two hours
after SEB exposure, total RNA was isolated from lung infiltrating mononuclear cells. (A)
A Heatmap depicting the differential expression of miRNA in the lungs of SEB exposed
mice compared to vehicle. The accompanying color scape depicts mean expression
values that are overexpressed (red) or underexpressed (green) above or below the mean
respectively. (B) Fold change distribution plot of 1111 mouse specific miRNA indicating
several unchanged, upregulated or downregulated miRNA. (C) A proportional Venn
diagram showing the number of miRNA that are overexpressed, underexpressed (< 2
fold) or unchanged after SEB exposure.
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Figure 3.5. Experimental validation of Top overexpressed and underexpressed
miRNA. Total RNA was obtained from the lung infiltrating mononuclear cells following
exposure to either vehicle of SEB. (A) q-RT PCR validation of the IPA generated Top
overexpressed miRNA. (B) q-RT PCR validation of the IPA generated Top
underexpressed miRNA. Snord96a was used as the small endogenous control and
expression of miRNA was normalized to vehicle. Data is represented as mean ± SEM
from replicate samples. Lung infiltrating mononuclear cells were pooled from 5 mice in
each group. Statistical significance is indicated as follows *p<0.05, *** P<0.001, ****
p<0.0001 (as compared to vehicle).
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Figure 3.6. In silico analysis of SEB-dysregulated miRNA. Ingenuity pathway analysis
(IPA) was used to analyze the miRNA that were significantly (<2 fold) altered. (A) Bar
graph highlighting the overall biological functions associated with the dysregulated
miRNA (B) Horizontal slice plot further depicting the percentage of the miRNAassociated molecules that can be attributed to specific biological functions.
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Figure 3.7. In silico analysis of the predicted mRNA targets. (A) IPA generated
network highlighting the interaction between validated miRNA (yellow) and their
respective target genes (blue). (B) Cytoscape generated network depicting Gene
Ontology (GO) enrichment terms and mapped for GO category: Immune response, using
Cytoscape with ClueGo and CluePedia applications. Two-sided hypergeometric test was
performed with kappa score threshold setting of 0.4. Benjamini-Hochberg statistical test
was used. The colored pie chart represents the highly enriched GO terms and the
diameter of the node in the map is directly proportional to the number of miRNA target
genes it contains.
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Figure 3.8. Experimental validation of miRNA target genes. (A) Schematic
illustration of SEB-induced overexpressed miRNA targeting the 3’UTR of potential
target genes. (B) q-RT PCR validation of SEB-induced miRNA mRNA targets. (C)
Schematic illustration of SEB-induced underexpressed miRNA that target the 3’ UTR of
potential target genes. (D) q-RT PCR validation of SEB-induced miRNA mRNA targets.
Data is represented as mean ± SEM from replicate samples. Lung infiltrating
mononuclear cells were pooled from 5 mice in each group. *p<0.05, ** p<0.01, ***
P<0.001, **** p<0.0001 (as compared to vehicle).
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Figure 3.9. miR-132 targets Foxo3. (A) Splenocytes obtained from mice were
transfected either with miR-132 mimic (Mimic) or Mock transfection control (Mock) for
24 hours. miR-132 and Foxo3 levels were determined by RT-PCR. (B) Splenocytes were
activated with (1μg/ml) and for 24 hours. Cells were then transfected with 100nM miR132 inhibitor (Inhibitor) or Mock transfection control (Mock) for another 24 hours.
Foxo3 levels were determined via RT-PCR. For miRNA normalization, Snord96_a was
used as internal control. For mRNA, β-actin was used as the internal control. Data is
represented as mean ± SEM from replicate samples statistical significance is indicated as
*p<0.05,**p<0.01,***P<0.001,****p<0.0001.
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CHAPTER IV: Δ9Tetrahydrocannabinol attenuates Staphylococcal enterotoxin Binduced inflammatory lung injury and prevents mortality in mice by modulation of miR17-92 cluster and induction of T-regulatory cells.
4.1 INTRODUCTION
Staphylococcal enterotoxin B (SEB) is a potent activator of the immune system resulting
in the clonal expansion of 5-30% of the T-cell pool and massive release of cytokines
(Choi et al., 1989; Faulkner et al., 2005). As a consequence, it is associated with a
number of diseases ranging from food poisoning, multi-organ failure and lethal toxicshock (Alouf et al., 2003; Dinges et al., 2000; Larkin et al., 2009). When inhaled, the
combination of cellular infiltration and cytokine production, results in vascular leak,
pulmonary edema, tissue damage and eventually acute inflammatory lung injury (Rao et
al., ; Rieder et al.). Due to its ability to be easily aerosolized and for its possible role as a
biological weapon, SEB is considered a Center for Disease Control and Prevention Category B select agent (Ulrich, 2001). While it is known that the interaction of SEB
with the T-cell receptor results in the activation of inflammatory pathways such as the
PI3K, MAPK and NFκB (Krakauer), a recent study from our laboratory has suggested
that microRNA (miRNA) may play an important role in SEB-mediated inflammation
(Rao et al.).
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miRNA are ~22 nucleotide, small, non-coding RNA that target mRNA, leading to its
degradation and/or translational repression (Guo et al.). Consequently, they control the
development and differentiation of various immune cells thereby leading to the regulation
of immune responses (Lindsay, 2008). Upon receiving inflammatory signals , active
changes occur within the transcriptional repertoire accompanied with altered expression
of a number of miRNA resulting in the up or downregulation of several important genes
(O'Connell et al.). One such modulator of gene expression is the miR-17-92 cluster.
Originally recognized as an oncogenic miRNA, this cluster that comprises of six miRNA
(miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a-1) is known to be an
important regulator of B and T-cell responses (Olive et al.). For example, miR-17-92
transgenic mice that express the cluster in both B and T cells develop lymphoproliferative
disease (Xiao et al., 2008). In addition, miR-19b and miR-17 within the cluster are
reported to regulate CD4 + T-cells and enhance Th1 responses (Liu et al.), thereby
demonstrating an important role for the cluster during inflammation.
Although current therapeutic strategies against SEB include the use of intravenous
antibodies as well as neutralizing antibodies against SEB-induced cytokines (Larkin et
al., ; Larkin et al., ; Matthys et al., 1995; Miethke et al., 1992) it’s efficacy remains
inefficient (Darenberg et al., 2004). Additionally, corticosteroids have been shown to
attenuate SEB-induced toxic shock and acute lung injury (Huzella et al., 2009; Krakauer
et al., 2006) , but the immunosuppressive property of corticosteroids is either
accompanied by a number of side-effects or have remained ineffective clinically (Bernard
et al., 1987; Meduri et al., 1998; Wajanaponsan et al., 2007) . As a result, there is a need
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for alternative agents that mitigate SEB-triggered inflammation with the potential to
modulate SEB-induced inflammatory miRNA.
Δ9-Tetrahydrocannabinol (THC) is a marijuana plant-derived cannabinoid known for its
robust anti-inflammatory properties (Klein, 2005; Nagarkatti et al., ; Nagarkatti et al.,
2009). It mediates its action by binding to two main cannabinoid receptors, CB1 and
CB2, found primarily in the brain and on immune cells respectively (Felder et al., 1998).
Previously, we have demonstrated that THC induces apoptosis in Jurkat leukemia T-cells
and dendritic cells (Do et al., 2004). THC suppresses the production of Th1 cytokines
IFN-γ and TNF-α (Klein, 2005; Klein et al., 1995; Srivastava et al., 1998; Sun et al.,
2008) , while increasing Th2 cytokines, IL-10 and TGF-β (Sun et al., 2008).
Additionally, while we have earlier reported that THC induces the production of myeloid
derived suppressor cells (MDSCs) (Nagarkatti et al.), we have for the first time
demonstrated that THC-mediated miRNA control the development of these MDSCs
(Nagarkatti et al.). Taken together, THC, by virtue of its anti-inflammatory properties
and its recently discovered ability to regulate miRNA expression could serve as an
effective therapeutic agent in the attenuation of SEB-mediated lung injury.
Thus, in the current study, we tested the hypothesis that THC treatment ameliorates SEBinduced toxicity through regulation of miRNA. Our data demonstrate that THC treatment
downregulates the members of the miR-17-92 cluster and ameliorates inflammatory
symptoms associated with SEB-exposure in the lungs.
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4.2 MATERIALS AND METHODS
Mice
Female C3H/HeJ mice (6-8 weeks) were purchased from The Jackson laboratory. All
mice were housed at the Animal Resource Facility (ARF), University of South Carolina,
under specific pathogen free conditions. All experiments involving the use of vertebrate
animals were conducted under protocols approved by the Institutional Animal Care and
Use Committee (IACUC) at USC.
SEB administration and THC treatment schedule
THC was provided by National Institute on Drug Abuse (Bethesda, MD) and SEB was
procured from Toxin Technologies (Sarasota, Florida). The treatment schedule comprised
of first injecting Vehicle or THC intraperitoneally (i.p) at a concentration of 20 mg/kg
body weight in a 100 μl volume dissolved in ethanol (Day 1). The following day (Day
2), THC (20 mg/kg) was once again administered via the i.p route. Thirty minutes later,
SEB was delivered as a ‘Dual Dose’ as described previously (Huzella et al., 2009).
Briefly, SEB dissolved in sterile PBS (2 mg/mL) was administered first by the intranasal
(i.n) route at a concentration of 5μg/mouse in a volume of 25 μL. Two hours later, a
second dose of SEB was delivered i.p at a concentration of 2 μg/mouse in a 100 μl
volume. On Day 3, mice were treated i.p. with THC (20 mg/kg). Survival of mice was
monitored up to 5 days after SEB exposure and any moribund mice were immediately
euthanized.
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Assessment of lung damage and function
Vascular leak in the lungs was determined as described (Rieder et al., ; Rieder et al., ;
Saeed et al., 2012). Briefly, mice were injected with 1% Evans blue in sterile PBS
intravenously (i.v) seventy-two hours after the second dose of SEB. Two hours later,
mice were euthanized and lungs were perfused with heparinized PBS. Lungs were
incubated in formamide at 37 ° C for 24 hours to extract the dye. The optical density
(O.D) of the supernatant was measured spectrophotometrically at 620 nm and percent
increase in vascular leak was calculated using the following formula - (O.D sample- O.D
control/O.D control)

x 100. Airway resistance was measured using whole body

plethysmography (Buxco, Troy, NY). Each mouse was restrained in a two-chamber
plethysmographic tube and were first allowed to acclimatize, followed by exposure to
saline for 2 minutes. This was followed by a 2 minute exposure to increasing doses of
methalcholine. The sRaw measurement at each methalcholine dose was calculated and
plotted as percent airway resistance. To examine lung morphology and histology, lungs
were fixed in 10% formalin, paraffin embedded and stained with hematoxylin and eosin
(H&E). The slides were observed under a light microscope at 20 x magnification.
Cell preparation and Flow cytometry
Vehicle, SEB+Vehicle and SEB+THC mice (5 mice per group) were euthanized 72 hours
after dual exposure to SEB. The lungs were perfused with heparinized PBS, harvested
and homogenized using Stomacher® 80 Biomaster blender from Seward (Davie, FL) in
10 ml of sterile PBS. Following washing with sterile PBS, cells were layered carefully
onto Ficoll-Histopaque ®-1077 from Sigma-Aldrich (St Louis, MO) at a 1:1 ratio.
Mononuclear cells were separated by density gradient centrifugation as a distinct layer as
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described (Rao et al., ; Rieder et al.) and enumerated by Trypan blue exclusion. To
determine the phenotypic characteristics of the infiltrating cells, mononuclear cells were
stained with the following fluorescent conjugated antibodies- Fluorescein isothiocyanate
(FITC) -conjugated anti-CD8 (clone: 53-6.7), anti-CD3 (clone: 145.2 C11).
Phycoerthyrin (PE)-conjugated anti-CD4 (clone: GK 1.5), anti NK1.1 (clone: PK136)
from Biolegend (San Diego, CA). FITC-conjugated anti-Vβ8 (clone: K516) from
Ebioscience (San Diego, CA). Intracellular staining of Foxp3 was carried out using
Biolegend’s Foxp3 Fix/Perm buffer set following manufacturer’s instructions and using
anti-foxp3 alexa flour 488 (clone MF-14) from Biolegend.
Cytokine Analysis
To assess serum cytokines, mice were bled three hours after dual exposure to SEB.
Cytokines from the BALF were obtained at the time by binding the trachea with a suture
and excising the lung along with the trachea, as described (Rao et al., ; Rieder et al.).
Sterile, ice-cold PBS was injected through the trachea to aspirate the fluid. The samples
were centrifuged to obtain the supernatants. All cytokine levels were measured using
Biolegend (San Diego, CA) ELISA MAX ™ standard kits.
miRNA target predictions and transfections
miRNA target candidate Pten was predicted using Ingenuity Pathway Analysis (IPA)
software from Ingenuity Systems ® (Mountain View CA). Briefly, highly predicted and
experimentally observed targets of the individual miRNA in the miR-17-92 cluster were
selected. A core analysis was carried out and significant (fishers exact test) biological
functions associated with the data set was generated. Additionally, a bar graph
highlighting key canonical pathways associated with the dataset was also generated.
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miRSVR score and alignment of miR-18a with Pten was obtained from
www.microRNA.org , target prediction website. To validate Pten as a target of miR-18a,
splenocytes from naïve C3H/HeJ mice were harvested and cultured in complete (10%
FBS, 10mM L-glutamine, 10mM Hepes, 50 μM β-Mercaptoethanol , and 100 μg/mL
penicillin) RPMI 1640 medium (Gibco Laboratories, Grand Island, NY). Cells were
seeded at 2 x 105 cells per well in a 24 well plate and transfected for 24 hours with 40nM
synthetic mmu-miR-18a (MSY0000528) or mock transfected with HiperFect transfection
reagent from Qiagen (Valencia, CA). For inhibition of miR-18a, SEB-activated cells
were similarly transfected for 24 hours with 100 nM synthetic mmu-miR-18a
(MIN0000528) or mock transfected.
Total RNA extraction and q-RT PCR
Total RNA (including small RNA) was isolated from lung-infiltrating mononuclear cells
or in vitro from splenocytes using miRNeasy kit from Qiagen (Valencia, CA) following
manufacturers instruction. The purity and concentration of the RNA was confirmed
spectrophotometrically using Nanodrop 2000c from Thermo Scientific (Wilmington,
DE). For miRNA validation and quantification, we used SYBR Green PCR kit (Qiagen)
and for mRNA validation, SSO Advanced ™ SYBR green PCR kit from Biorad
(Hercules, CA). Fold change of miRNA was determined by normalization to Snord96_a
internal control, whereas, mRNA levels were normalized to β-actin. The following q-RT
PCR primers were used: β-actin (F) 5’GGCTGTATTCCCCTCCAT G-3’ and (R) 5’CCAGTT GGTAACAATGCCATGT-3’; Foxp3 (F) 5’ AGCAGTCCACTTCACCAAGG
3’ and (R) 5’ GGATAACGCCAGAGGAGCTG 3’; Pten (F) 5’
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TGGATTCGACTTAGACTTGACCT 3’ and (R) 5’ GCGGTGTCATAATGTCTCTCAG
3’.
In vitro cell culture assays
Splenocytes from naïve C3H/HeJ mice were harvested and cultured in complete RPMI.
Cells were seeded at 1x106 cells per well of a 96 well plate and either left unstimulated or
stimulated with SEB (1μg/ml). Cell were either treated with THC (20μM) or with AKT
1/2 kinase inhibitor (A6730) from Sigma-Aldrich at the doses indicated. Twenty-four
hours later cells were harvested and centrifuged. The cell supernatants were collected for
assessment of IFN-γ levels by ELISA and the cell pellets were used for total RNA
extraction and q-RT PCR. Cell proliferation was determined by incubating the cells as
described above for forty-eight hours. 3[H]-Thymidine (2μCi) was added to the cell
cultures in the last 12 hours of incubation. Cultures were collected using a cell harvester
and thymidine incorporation was measured using a scintillation counter (Perkin Elmer).
Statistical analysis
All statistical analyses were carried out using GraphPad Prism Software (San Diego,
CA). In all experiments, the number of mice used was 4-5 per group, unless otherwise
specified. Results are expressed as means ± SEM. Student’s t-test was used to compare
two-groups, whereas multiple comparisons were made using one-way analysis of
variance (ANOVA), followed by post hoc analysis using Tukey’s method. A P-value of
< 0.5 was considered statistically significant. Individual experiments were performed in
triplicate and each experiment was performed independently at least three times to test
reproducibility of results. Survival analysis was carried out using a Log-rank test.
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4.3 RESULTS
THC strongly attenuates SEB-mediated inflammation and prevents acute mortality
Dual SEB exposure has been previously used to study acute lung injury leading to 100%
death in C3H/HeJ mice (Huzella et al., 2009). In the current study, we found that 100%
of the mice exposed to SEB died between 96 and 120 hours. Remarkably, in THC treated
groups, all mice survived (Figure 4.1A). SEB exposed mice displayed signs of lethargy,
hunching, ruffled fur and respiratory stress; whereas THC treated mice appeared
healthier. To gauge the extent of pulmonary damage , we measured airway resistance
using whole body plethysmography and found that SEB exposure resulted in a significant
percent increase in airway resistance, while THC treated mice recorded specific airway
resistance (sRAW) values similar to Vehicle alone (Figure 4.1B). Further, we measured
the percent increase in vascular leak by administration of Evans blue dye. Evans blue
binds to serum albumin and is a measure of vascular permeability, as shown previously
(Rieder et al.). Our results demonstrated that while SEB exposure had a profound
increase in vascular leak when compared to Vehicle only, THC treatment caused a
significant decrease in vascular leak (Figure 4.1C). Acute inflammatory lung injury is
characterized by massive immune cell infiltration into the lung. Accordingly, we found
an increase in the total number of mononuclear cells after SEB exposure and a
subsequent decrease with THC treatment (Figure 4.1D). This was confirmed by
histopathological examination of the lungs whereby SEB exposed mice displayed an
increase in infiltrating immune cells around the bronchioles and air vessels while the
THC treated mice, yielded significantly fewer layers (Figure 4.1E). To identify the
immune subsets amongst the infiltrating mononuclear cells, we stained the cells with
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various fluorescein-conjugated anti-mouse antibodies. We found that exposure to SEB
resulted in increased CD3+ (T-cells), CD4+ (T-helper cells), CD8+ (Cytotoxic T-cells),
Vβ8+ NK+ (Natural Killer cells) and NK1.1+CD3+ (Natural killer T-cells), THC
treatment caused an overall decrease in the absolute cell numbers (Fig 4.1F).
A hallmark of SEB-mediated inflammation is the abundant release of cytokines. To
determine if THC was able to blunt cytokine secretion, we first analyzed the
concentration of early cytokines IL-2 and MCP-1 in the serum. Mice were bled at 3
hours, 6 hours, and 24 hours after SEB exposure. While IL-2 and MCP-1 peaked at 3
hours (data not shown), we found that the THC treated group showed diminished
secretion of both IL-2 and MCP-1 as early as 3 hours after SEB exposure (Figure 4.2A),
supporting the potent anti-inflammatory role of THC in this model. Moreover, an
examination of cytokines in the broncheoalveolar lavage fluid (BALF) revealed that THC
treatment led to the substantial decrease in IFN-γ, IL-6, IL-12 and IL-10 (Figure 4.2B).
Overall, these data suggest that THC attenuates SEB-induced immune cell infiltration,
decreases early and late cytokine secretion, and prevents mortality of the mice.
THC modulates the expression of the miR-17-92 cluster
Antigenic stimulation and the activation of the T-cell receptor is known to result in the
induction of miR-17-92 cluster (Wu et al., 2012). Consequently, we reasoned that SEB
exposure would lead to the expression of this prominent miRNA cluster. Seventy two
hours after exposure to SEB, we measured miRNA expression in mononuclear cells
isolated from the lung by q-RT PCR. Interestingly, we observed high levels (up to 600
fold) of the miRNA cluster, although individual miRNA were induced to different levels.
More interestingly, THC treatment was able to down-regulate the individual members of
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the cluster significantly (Figure 4.3), strongly suggesting that THC may exhibit its
powerful anti-inflammatory activity through the modulation of inflammatory miRNA.
miR-17-92 cluster is linked to the activation of the PI3K/AKT/ pathway
Because SEB exposure resulted in the strong induction of the miR-17-92 cluster, we
sought to explore the significance of this particular cluster in our study. Therefore, we
carried out computational analysis on the highly predicted and experimentally observed
targets of the cluster (miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-92a-1)
using Ingenuity Pathway analysis (IPA). IPA results suggested that the members of the
cluster were involved in a number of biological functions relevant to the expansion of Thelper lymphocytes, the development of regulatory T-cells, the proliferation of cells and
apoptotic processes (Figure 4.4A). In addition, analysis of the canonical pathways
associated with the cluster indicated the involvement of the MAPK, NFκB, and
PI3K/AKT signaling pathways, (processes that are all reported to be SEB-triggered).
Interestingly, while the PTEN signaling and mTOR pathways were highlighted by IPA as
significant (Figure 4.4B), pathway analysis also indicated that the miRNA in the cluster
are highly predicted or experimentally observed to converge on Pten (Figure 4.4C). As a
result, we reasoned that the SEB-induced miRNA cluster is involved in the activation of
the PI3K/AKT signaling pathway while THC mediated down-regulation of this cluster
inhibits the aforementioned activation. To test if the cluster was indeed involved in the
activation of the PI3K/AKT pathway, we activated splenocytes with SEB and treated
them with an AKT1/2 inhibitor. Amongst the individual members of the cluster that were
upregulated by SEB activation (data not shown), miR-18a in particular was significantly
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downregulated upon AKT1/2 inhibition (Figure 4.5A). This indicated the involvement of
miR-18a in SEB-mediated activation of the PI3K/AKT pathway.
miR-18a targets Pten, a negative regulator of the PI3K/AKT Pathway
Previous reports have established that a principal target of the miR-17-92 cluster is PTEN
(phosphatase and tensin homologue), an antagonist of the PI3K/AKT pathway (Liu et al.,
; Xiao et al., 2008) . Using www.miRNA.org alignment tool, we found that miR18a is
predicted to target the 3’ UTR of Pten with a good miRSVR score of -0.1453 (Figure
4.5B). To assess if miR-18a indeed targets Pten, we first transfected splenocytes with
synthetic miR-18a mimic. Interestingly, we found that miR-18a mimic repressed Pten
(Figure 4.5C). Further, the inhibition of SEB-activated cells with a miR-18a synthetic
inhibitor led to the derepression of Pten (Figure 4.5D), suggesting that miR-18a,
belonging to the cluster, plays a prominent role in the repression of Pten and
consequently results in the activation of SEB-triggered PI3K/AKT pathway. Earlier we
observed that THC was able to dramatically decrease the expression of the miRNA
cluster (Figure 4.3). Therefore, we wondered if THC treatment would be able to
subsequently restore the SEB-induced suppression of Pten. Upon assessing Pten
expression in lung infiltrating mononuclear cells by q-RT PCR, we observed that while
SEB exposure indeed resulted in the repression of Pten, THC treatment led to its increase
(Figure 4.5E). Taken together, these data indicated that THC, via down-regulation of
miR-18a, leads to the release of Pten and in doing so, may act as an AKT inhibitor.
THC functions as an AKT inhibitor
The activation of the PI3K/AKT pathway leads to cellular proliferation, the release of
IFN-γ and inhibition of T-regulatory cells. Our results suggested that by antagonizing the
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PI3K/AKT axis via the down-regulation of miR-18a and the subsequent release of Pten,
THC may mimic the properties of an AKT inhibitor. To confirm this notion, we first
compared the properties of THC with an AKT inhibitor on IFN-γ production in vitro.
Splenocytes were activated with SEB and treated with THC or AKT inhibitor. The
resulting concentration of IFN-γ was measured by ELISA. As expected, AKT inhibition
led to the dose dependent decrease of IFN-γ (Figure 4.6A). Interestingly, THC treatment
also demonstrated a trend in the dose-dependent decrease of IFN-γ, with a significant
blunting of this cytokine at the highest dose (Figure 4.6A). Further, when cellular
proliferation of cells was assayed by thymidine incorporation, we observed a similar
dose-dependent decrease in cellular proliferation (Figure 4.6B) with THC and the AKT
inhibitor. Moreover, the interruption of AKT signaling results in the induction of
CD4+Foxp3+ T-regulatory cells (Merkenschlager et al., ; Sauer et al., 2008). Upon
activating splenocytes with SEB in vitro and treating with either the AKT inhibitor or
THC, we found significant induction of foxp3 (Figure 4.6C) compared to SEB alone. The
induction was further confirmed by flow cytometric analysis and q-RT PCR of lung
infiltrating mononuclear cells (Figure 4.6D). Taken together, these data indicate that THC
inhibits AKT signaling by modulating miR-18a and allowing for the release of Pten. The
resulting decrease in cellular proliferation, IFN-γ production and induction T-regulatory
cells, prevent SEB-mediated acute inflammatory lung injury and death.
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4.4 DISCUSSION
In the current study, we investigated the role of THC in preventing SEB-induced
inflammatory lung injury and subsequent mortality via the modulation of miRNA.
Through the use of q-RT PCR and computational tools, we found that the SEB-induced
miRNA 17-92 cluster which was overexpressed in the lungs is down-regulated with THC
treatment. Specifically, by performing gain-and loss-of function analysis using synthetic
mimic and inhibitor, we confirmed the predominant role of miR-18a in the SEB-mediated
activation of the PI3K/AKT pathway. Our studies also suggested that THC may function
as an antagonist of the AKT pathway, at least in part, by its ability to significantly
decrease the expression of miR-18a. Our results highlight the role of miRNA in
facilitating severe inflammation and the ability of cannabinoids to suppress its
expression. Importantly, we show that the previously reported potent anti-inflammatory
role of THC can be explained, at least in part, by its ability to act upon SEB-mediated
miRNA.
SEB specifically expands a large number of T cells, by virtue of engaging the Vβ8
region of the T-cell receptor (TCR) following binding to the MHC II on antigen
presenting cells (APCs) (Choi et al., 1989; Hurley et al., 1995). Consequently, SEB
exposure leads to the massive release of inflammatory cytokines, proliferation of T cells,
tissue damage and SEB-mediated shock (DeVries et al., 2011; Kissner et al., 2011;
Miethke et al., 1992). Most models developed to study the effects of SEB exposure in
mice, have employed the use of transgenic mice or external agents such as LPS or Dgalactosamine to potentiate SEB-mediated inflammatory response (DaSilva et al., 2002;
Savransky et al., 2003). In the dual administration of SEB as used in this study,
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microgram quantities of SEB were sufficient to cause inflammatory symptoms and
toxicity reminiscent of SEB exposure in humans (Huzella et al., 2009). In this model,
mice succumb to SEB-mediated shock and severe respiratory damage (Huzella et al.,
2009). Consistent with these reports, we observed an overall increase in mononuclear
cells in the lung, particularly T cells. We also found SEB-mediated release of early
monocyte and T-cell recruiting cytokines IL-2 and MCP-1 in the serum. Additionally, we
noted the abundant release of late cytokines, especially IFN-γ in the BALF of the lungs
resulting in compromised vascular permeability and the ultimate death of mice.
Earlier studies have reported that the molecular mechanism of action behind SEBmediated inflammation and toxicity begins soon after the activation of the TCR
(Goldbach-Mansky et al., 1992; Linsley et al., 1993). Following the increase in costimulatory molecules, a number of signaling pathways such as the MAPK, ERK, JNK,
and PI3K/AKT are simultaneously activated (Krakauer). These pathways culminate in
the stimulation of various transcription factors such as NFκB and NFAT (Trede et al.,
1995; Tsytsykova et al., 2000). However, with the recent discovery of miRNA, our
understanding of the molecular mechanisms that govern gene regulation has been
revolutionized. It is now evident that these small single- stranded RNA molecules are
capable of targeting the 3’ UTR of mRNA thereby regulating biological processes such
as cellular proliferation, differentiation and development(Davidson-Moncada et al.).
miRNA are also induced upon a number of inflammatory cues and subsequently
influence immune responses and immune cell development (Dai et al.).
The miR-17-92 cluster found on mouse chromosome 14 is amongst the many miRNA
that are found to be overexpressed under inflammatory conditions (Sonkoly et al.,
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2009a). It is transcribed as a single polycistronic unit and comprises of six miRNA- miR17, miR-18a, miR-19a, miR-19b-1, miR-20a, and miR-92-1(Wu et al.). Previously, it has
been shown that naïve CD4+ T-cells polarized under Th1 inducing conditions show a
significant increase in the miR-17-92 cluster. (Sasaki et al., 2010) Further, a recent report
demonstrated the critical role of the cluster in the expansion of T-cells upon antigenicstimulation, although they observed that individual miRNA within the cluster have
differential roles in promoting Th1 responses.(Liu et al.) Prompted by these reports, we
first investigated the role of miRNA in facilitating SEB-mediated lethality in mice and
found that SEB exposure led to the overexpression of the miR-17-92 cluster in lung
infiltrating mononuclear cells. Similar to previous studies, we also found that the
members of the cluster, were expressed to different levels, suggesting that one or more
miRNA within the cluster may play a more prominent role.
It was reported that the overexpression of miR-17-92 cluster causes lymphoproliferation,
autoimmunity and premature death of mice by targeting Pten, a well-established
antagonist of the PI3K/AKT pathway (Xiao et al., 2008). In the present study, we
demonstrate that Pten is suppressed after SEB exposure. Whereas previous studies have
shown a primary role for miR-19b in the targeting of Pten (Liu et al., ; Olive et al.,
2009), we attribute the SEB-mediated suppression of Pten to the predominant role of
miR-18a. These data are surprising because while we demonstrate a clear reversal in the
suppression of Pten using a miR-18a inhibitor, a few reports have demonstrated its role in
inhibiting cellular proliferation(Liu et al., ; Tsang et al., 2009). It is possible that the
functional targets of miRNA may differ based on the type of antigenic stimulation.
Alternatively, the critical timing of SEB dual administration could contribute to the

82

specific regulation of Pten by miR-18a. Moreover, it is also possible that because the
cluster comprises of six miRNA with several predicted target genes, Pten is simply one
of many genes simultaneously targeted during the course of inflammation. Nevertheless,
our results show a clear induction of the miR-17-92 cluster and specifically the
suppression of Pten by miR-18a.
The anti-inflammatory and immunosuppressive effects of THC are diverse and function
effectively to abrogate a number of inflammatory processes. For example, THC has
previously been reported to prevent the development of a murine model of multiple
sclerosis and colitis (Jamontt et al., 2010; Lyman et al., 1989). In a mouse model of ConA induced hepatitis, we have demonstrated its ability to act on acute inflammation, where
it not only decreased the production of inflammatory cytokines, but also reduced cellular
proliferation(Hegde et al., 2008). Consistent with these reports, our data demonstrate a
significant reduction in infiltrating immune cells in the lung, blunting of cytokines as
early as 3 hours after SEB exposure and more astonishingly, the 100% survival of mice.
We have previously demonstrated that THC’s anti-inflammatory properties can be
credited, in part, to the induction of immunosuppressive cells such as regulatory T-cells
(T-regs) and myeloid derived suppressor cells (MDSC) (Hegde et al., 2008; Nagarkatti et
al.). Recently, we have identified a novel role for THC in modulating miRNA involved
in the development of MDSCs (Nagarkatti et al.), a finding that could shed mechanistic
light on THC’s mode of action . Thus, we rationalized that THC could potentially exert
its strong anti-inflammatory activities by modulating SEB-induced miRNA. Our present
findings validate our hypothesis and we observed a potent down-regulation of the miR17-92 cluster. Inversely, our results demonstrate the derepression of Pten suggesting that
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THC, via the down regulation of the cluster might be an inhibitor of the PI3K/AKT
pathway. Interestingly, earlier studies in cancer models have demonstrated that THC
disrupts the PI3K/AKT signaling pathway (Greenhough et al., 2007; Leelawat et al.,
2010). However, in light of our current observation that it modulates key miRNA, its
anti-inflammatory properties via its role as a PI3K/AKT inhibitor, is made more evident.
The disruption of the PI3K/AKT/mTOR axis using AKT inhibitors has been previously
reported to decrease cellular proliferation, induce apoptosis and decrease IFN-γ
production (Mandal et al., 2005; Shin et al., 2002). Further, Rapamycin, an inhibitor of
mTORC1, specifically diminishes SEB-induced IL-2 ,IFN-γ and T-cell proliferation
(Krakauer et al., ; Krakauer et al.). In line with these reports, our results also
demonstrated decreased cellular proliferation and IFN-γ production with THC treatment.
Additionally, the PI3K/AKT activation of PTEN deficient T-cells, led to the suppression
of CD4+Foxp3+ T-cells, which was reversed with PI3K/AKT inhibition (Sauer et al.,
2008). Similarly, we observed the induction of T-regulatory cells in the lung upon THC
treatment, further confirming that THC is an inhibitor of the PI3K/AKT signaling
pathway, and that part of its mechanism involves down-regulation of the miR-17-92
cluster, particularly miR-18a.
Taken together, our data demonstrate that THC is a strong anti-inflammatory agent
capable of rescuing mice from SEB-mediated toxicity and death. By affecting the SEBinduced miR-17-92 cluster, it restores Pten, and enables the proper regulation of the
PI3K/AKT signaling pathway. Consequently, it reduces cellular proliferation, diminishes
the production of pro-inflammatory cytokine and induces T-regulatory cells (Figure 4.7).
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Figure 4.1. THC prevents mortality and alleviates SEB-induced inflammation in the
lung (A) Survival curve of mice receiving SEB+ Vehicle when compared to mice treated
with SEB+THC. (B) Measurement of airway hyperreactivity [sRAW] using whole body
plethysmography. Mice were acclimatized in a two-chamber plethysmograph tube and
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were first exposed to aerosolized saline followed by increasing doses of methalcholine.
Data was recorded for 4 minutes and the sRAW value was calculated over saline. (C)
Assessment of vascular leak in the lungs was carried out 72 hours after SEB exposure.
Mice were injected with 1% Evans blue i.v. Two hours later, the lungs were perfused and
placed in formamide at 37 °C for 48 hours. Percent vascular leak was calculated by
measuring absorbance at 620 nm. (D) Total number of infiltrating mononuclear cells
were determined 72 hours after SEB exposure. Lungs were mechanically macerated and
the suspension was placed on a Ficoll gradient. Mononuclear cells thus obtained, were
counted by trypan blue exclusion method and enumerated. (E) Histopathological
examination of lungs as determined by Hemotoxylin and Eosin staining. Arrows indicate
infiltrating immune cells around a capillary. Total layers of infiltrating cells were counted
around 10 different capillaries and enumerated in the bar graph. (F) Flow cytometric
analysis to identify immune subsets was carried out. Mononuclear cells were stained with
antibodies against T-cells (CD3), T-helper cells (CD4), cytotoxic T-cells (CD8), Vβ8region of the T-cell receptor (Vβ8), natural killer cells (NK) and natural killer T-cells
(NKT). Absolute cell numbers of various subpopulations was calculated using the
formula: Total number of cells isolated from the lungs x percent of specific cells/100,
and plotted as a bar graph. Bar graphs summarize the means ±SEM from 3-5 independent
experiments.
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Figure 4.2: THC decreases SEB-induced cytokine secretion (A) Measurement of early
cytokines, IL-2 and MCP-1 in serum 3 hours after SEB exposure. (B) Cytokine
measurement of IFN-γ, IL-12, IL-10 and IL-6 in the broncheoalveloar lavage fluid
(BALF). All cytokines concentrations were determined using Enzyme linked
immunosorbent assay (ELISA). Bar graphs summarize the means ±SEM from 3-5
independent experiments. For cytokines from the serum, unpaired, two-tailed t-test was
used to determine significance from SEB.
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Figure 4.3: THC significantly down-regulates SEB-induced expression of the miR17-92 cluster. Real time (RT) PCR validation of the individual miRNA (miR-17, miR18a, miR-19a, miR-19b-1, miR20a and miR-92a-1) of the miR-17-92 cluster obtained
from lung infiltrating mononuclear cells. Data are normalized to internal control
Snord_96a. Statistical significance was assessed using ANOVA, tukey’s multiple
comparison test.
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Figure 4.4: The involvement of the miR-17-92 cluster in key biological pathways (A)
Graphical representation of the biological functions associated with significantly
upregulated SEB-induced miRNA as determined by Ingenuity ® pathway analysis (IPA)
(B) Canonical pathways associated with miRNA target genes. IPA was used to filter
highly predicted and experimentally observed targets of only the significantly
upregulated miRNA in response to SEB. A graphical representation of the significant
(fisher’s exact test) pathways of these particular target genes was generated. (C) IPA
pathway demonstrating the convergence of the members of the miR-17-92 cluster on
Pten.
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Figure 4.5: miR-18a targets Pten, an inhibitor of the PI3K/AKT pathway. (A) RTPCR of miR-18a levels in splenocytes that were activated with SEB and treated with
AKT inhibitor. miRNA levels measured relative to Snord_96a internal control (B) Target
prediction of miR-18a using miRanda (www.microrna.org), showing the alignment of the
mature miRNA to the 3’ UTR of Pten mRNA. The miRSVR score represents the
probability of mRNA target down-regulation and the cut-off for a good score was set at ≤
-0.01. (C) RT-PCR quantification of miR-18a and its target Pten. Splenocytes were
transfected with 40 nm of miR-18a mimic for 24 hours. (D) RT-PCR quantification of
miR-18a and Pten after transfection with a synthetic miR-18a inhibitor. Splenocytes that
were activated with SEB (1μg/ml) were also transfected with miR-18a inhibitor for 24
hours. (E) Real-time PCR quantification of Pten levels in lung infiltrating mononuclear
cells. All miRNA levels were measured relative to internal control Snord_96a and
mRNA levels were normalized to β-actin. Statistical significance was assessed using
ANOVA, tukey’s multiple comparison test.
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Figure 4.6 : THC is an inhibitor of the AKT pathway and leads to the induction of
CD4+Foxp3+ T-regulatory cells (A) IFN-γ levels in supernatants of splenocytes that
were activated with SEB and treated with varying doses of THC or AKT inhibitor. (B)
Thymidine incorporation to measure proliferation of splenocytes activated with SEB or
treated with the indicated doses of THC or AKT inhibitor. (C) RT-PCR of Foxp3 levels
in splenocytes that were treated either with THC or AKT. mRNA levels measured
relative to β-actin. (D) Flow cytometric analysis of CD4+Foxp3+ T-regulatory cells in
lung infiltrating mononuclear cells for the groups indicated. The bar graph represents the
RT-PCR expression of Foxp3 in lung infiltrating mononuclear cells. In all in vitro
experiments, Splenocytes were activated with 1μg/ml SEB. Statistical significance was
assessed using ANOVA, tukey’s multiple comparison test.
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Figure 4.7: Schematic of the proposed working model. SEB administration leads to the
activation of the PI3K/AKT pathway via the induction of the miR-17-92 cluster and the
subsequent down-regulation of Pten. As a result, SEB exposure leads to increased
cellular proliferation, cytokine production, pulmonary damage and the acute mortality.
The down regulation of the cluster by THC restores Pten levels and allows for the
inhibition of the PI3K/AKT axis. This leads to attenuation of acute inflammatory lung
injury and induction of T-regulatory cells, which together prevent SEB-induced
mortality.
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CHAPTER V: SUMMARY AND CONCLUSION

It is evident that the scientific community is making great strides in the study of miRNA.
In nearly a decade, these novel regulators of gene expression have been recognized for
their ability to control almost every biological process. In naïve conditions, they exist to
maintain homeostasis, influence cellular development and commitment to specific
lineages. In stress and inflammation, their impact is made even more apparent, as their
massive dysregulation contributes significantly to worsening of disease. miRNA biology
is made complex given that a single miRNA can have hundreds of target genes and that
inflammatory conditions lead to the alteration of a number of miRNA. Thus, it is
imperative that we first present an overview of the importance of the miRNA signaling
pathways and then begin to dissect the involvement of individual miRNA. In doing so,
we can identify unique miRNA biomarkers and aim to develop therapeutic agents that
directly or indirectly target miRNA.

In the studies undertaken here, we have explored the impact of SEB exposure in mouse
models of acute inflammatory lung injury. Although, previous studies have demonstrated
that SEB, a superantigen causes an exaggerated immune response and subsequent
damage, the molecular mechanism behind its actions were attributed to inflammatory
signaling pathways downstream of TCR activation. We hypothesized that if
inflammatory cues are known to induce miRNA, then SEB-induced antigenic stimulation
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should also lead to expression of miRNA. Indeed, our studies in two mouse models of
SEB-induced lung injury confirmed the dysregulation of miRNA. In silico analysis
revealed that these miRNA perform biological functions pertaining to cellular
proliferation, T-cell activation, and cytokine production. The interaction between miRNA
and their respective target genes was further found to involve the activation of key
inflammatory signaling pathways known to be associated with SEB activation
experimentally. Additionally, we focused on the role of highly overexpressed miRNA to
determine its involvement to SEB-mediated damage. In the less severe form of acute
inflammation, we found that miR-155 and its respective target gene Socs1 could explain
the copious amounts of IFN-γ produced and the subsequent damage inflicted to the lung.
In the model that resulted in the death of mice, we observed that a miRNA cluster (miR17-92) commonly studied in cancer, was activated following SEB exposure.
Identification of the role of this cluster in inflammation, led us to the SEB mediated
activation of the PI3K/AKT signaling pathway via the suppression of Pten, a negative
regulator of AKT signaling. We also found that overexpression of miR-132 was linked
with repression of Foxo3, a regulator of T-cell proliferation and activation.

Since SEB is a strong pro-inflammatory inducing agent, we sought to counter its effects
with an equally potent anti-inflammatory compound, THC. In choosing this particular
therapeutic agent, we were aware that some of its previously studied functions included
its ability to decrease inflammatory cytokines, inhibit cellular proliferation and induce
immunosuppressive cells such as the MDSCs or T-regs. Indeed, we demonstrated that
THC could prevent SEB-triggered acute mortality of mice by ameliorating inflammation
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and inducing T-regs, however, for the first time we established that it does so by
modulating miRNA. In conclusion, our studies have helped understand that the miRNA
control of gene expression lies at the heart of pro-inflammatory (SEB-induced) and antiinflammatory (THC-mediated) immune responses. By further studying the role of these
small RNA molecules and their dynamic interaction with their target genes, we can better
develop miRNA related therapeutics to prevent and treat inflammatory diseases.
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